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“Chance favors a prepared mind” – Louis Pasteur at Pouilly le Fort
In a public defense for the French Academy of Science, Pasteur inoculates several
livestock using his inactivated anthrax vaccine. One change has been made to his
protocol though; the inoculation dose of anthrax is now going to be significantly higher
than what was thought. After inoculation, the press covering the event asks Pasteur if he
is nervous for the results. He indicates that he is not because chance favors a prepared
mind. After one week, all of the animals inoculated with the vaccine were alive, while all
of the uninoculated were dead or dying.
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Abstract
JORDON DALE GRUBER. Role of 2,4-Dihydroxyquinoline (DHQ) in Pseudomonas
aeruginosa Pathogenicity. (Under the direction of Yong-Mei Zhang).

Bacterial group behaviors are advantageous during an infection to thwart immune
cell attack and resist deleterious changes in the environment. Bacteria use a chemical
messaging system in order to coordinate the phenotypes in the environment. In
Pseudomonas aeruginosa, the Pseudomonas quinolone signal (Pqs) quorum-sensing
system produces alkylquinolones that regulate virulence factor production and also
perform extracellular roles. Two alkylquinolones, 2-heptyl-4-quinolone (HHQ) and 2heptyl-3-hydroxy-4-quinolone (PQS) activate transcriptional regulator PqsR for
subsequent production of quinolones and phenazines, iron chelation, and autolysis. The
most abundant quinolone produced from the Pqs system is 2,4-Dihydroxyquinoline
(DHQ); however, DHQ has no known function. We demonstrated mutants only able to
produce DHQ maintained virulence towards a model of bacterial infection and in vitro
virulence factor production. Furthermore, we identified a potential extracellular role for
DHQ against both epithelial cells and macrophages that resulted in reduced replication,
viability, and cytokine production. As a signaling molecule, DHQ activated PqsR to bind
to the promoter region of pqsA for transcription. Finally, we determined the impact of
DHQ on cystic fibrosis patient health and its correlation to lung function. Taken together,
our findings suggest DHQ is capable of activating PqsR as a redundant QS molecule, but
may play a significant role against host cells during infection.
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Chapter 1: Introduction to Pseudomonas aeruginosa pathogenicity, quorum sensing,
and the role of DHQ.
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1.1 Significance of P. aeruginosa infections

Pseudomonas aeruginosa is a motile, Gram-negative bacterium found in different
soil and aquatic environments. In order to survive on various carbon and nitrogen
sources, P. aeruginosa possesses a versatile metabolic system that sustains the bacterium
even in nutrient-poor conditions. Although P. aeruginosa uses oxygen as a terminal
electron acceptor for oxidative phosphorylation, P. aeruginosa contains three separate
systems for acquiring nitrogen and synthesizing nitrate as an alternative electron acceptor
under anaerobic conditions. Among the different environments colonized by P.
aeruginosa, the bacteria can live as a single cell or in a complex community.
P. aeruginosa is an increasingly prevalent environmental and nosocomial
pathogen. Intact immune systems often prevent P. aeruginosa colonization, but
furnishing a surface to grow on or a compromised immune system can predispose
patients to infection [1, 2]. Implanted medical devices provide a surface for P.
aeruginosa to colonize, which leads to biofilm formation and infection [3, 4]. Ventilated
patients are also susceptible to P. aeruginosa infections because the ventilator system
generates a warm, moist environment for bacterial growth and subsequent access to
anesthetized or damaged tissue [5, 6]. Although not widely publicized in the media,
contact-lenses can also be colonized by P. aeruginosa, which can lead to corneal
infections severe enough to result in blindness [7].
Overall, patients with compromised immune systems are most at risk to acquire a
P. aeruginosa infection. Diabetic patients have poor circulation as a result of damaged
blood vessels and tissues not efficiently replenished with cycled blood. Subsequently,
9

pressure ulcers and wounds from these patients are no longer adequately protected from
the immune system and subject to P. aeruginosa chronic infections [8]. P. aeruginosa
colonizes burn wound patients because the charred dermal layers provide a surface not
protected by the immune system [9]. These patients face overwhelming bacterial
infections, especially those who have wounds covering over 40% of their bodies. Due to
the ability of P. aeruginosa to resist antibiotic treatments, patients infected with P.
aeruginosa require intense therapies to overcome infection. The cost of treating P.
aeruginosa is on the rise worldwide, and in America, the annual cost of treating P.
aeruginosa infections is in the billions [10, 11].
Cystic fibrosis (CF) is an autosomal recessive genetic disorder and the most
common heritable disorder among Caucasians. CF patients possess a mutation in the
cystic fibrosis transmembrane conductance regulator (CFTR), which results in a
dysfunctional chloride channel and disrupted surface-liquid homeostasis [12]. Over 2,000
different mutations exist that can cause disease, but the most common CF-causing
mutation is a deletion of phenylalanine 508 (∆F508) [13]. Normal lungs contain a thin
layer of mucus over the epithelial cells, which bind to inhaled microorganisms. Over
time, expelling or swallowed mucus prevents most pathogens from establishing an
infection. CF patients accumulate thick mucus in their lungs, which contains
macromolecules and salt build-up above the epithelial cells [14]. As a result of increased
mucus viscosity and decreased ciliary beat, patients with CF cannot effectively clear their
lungs. In the thick mucus, pathogens establish infections, gather abundant nutrients, and
avoid attack by host immune cells. Altogether, the paradigm of CF disease revolves
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around three deleterious effects: decreased lung clearance, increased infections with
microbial pathogens, and increased inflammatory response [15].
In the US, more than 30,000 CF patients must receive intense, life-long treatments
that include airway-clearance respiratory therapy, steroids, and daily antibiotics to
prevent severe infection and lung damage [16]. Many CF patients are now living close to
forty years (median survival) as a result of new antibiotics and better supportive therapies
[17]. Within the CF population, P. aeruginosa colonizes up to 80% of patients, of which,
P. aeruginosa colonization is associated with earlier morbidity and mortality [18, 19]. CF
patients often acquire P. aeruginosa later on in life and may be previously infected with
other pathogens. During their teenage years, CF patients initially isolate P. aeruginosa
from their lungs and harbor the bacterium for the duration of the their disease [20].
Patient exacerbations, which may be related to increasing P. aeruginosa colonization,
contribute to lung damage and lower patient expiratory lung volume over time.
Eradication of P. aeruginosa is a priority in the care of CF patients, but traditional
antibiotic therapies have had little success in eliminating the bacterium after an initial
positive culture or following chronic colonization.
The success of pathogenic P. aeruginosa is based on its ability to adapt and
control the environment within the lungs [21]. Specifically, P. aeruginosa utilizes a
variety of nutrients and form communities that adjust quickly to changes in the
environment. P. aeruginosa also ‘senses’ and attacks other microorganisms competing
for the same niche [22]. This competition is highlighted in CF sputum samples that have
been enumerated for bacterial growth and high densities of the bacterium, upwards of 108
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to 109 CFU/ml, demonstrating the ability to thrive in the lungs while facing the host
inflammatory response and daily antibiotic therapy [23, 24].
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1.2 Mechanisms of antibiotic resistance in P. aeruginosa

Eradicating P. aeruginosa is difficult due to both intrinsic and acquired antibiotic
resistance mechanisms. Of the intrinsic resistance mechanisms, those contained in the
membrane play major roles. Porins in the outermembrane allow for the exchange of small
hydrophilic compounds [25]. Antibiotics take advantage of the porins to gain access to
the inside of the cell [26]. P. aeruginosa porins can be smaller (allow molecules <200 da
to pass through) than normally found in Gram-negative bacteria such as E. coli (allow for
molecules <500 da to pass through), which impede antibiotics from moving across the
membrane [27, 28]. Efflux pumps in the membrane also play a role in antibiotic
resistance because they secrete a variety of toxic compounds and make entire classes of
antibiotics useless [29, 30]. These mechanisms within the membrane protect individual P.
aeruginosa cells, while other resistance mechanisms are community-dependent.
A biofilm is a community lifestyle of bacteria that provides cellular heterogeneity
and protection from chemical assaults in the environment. P. aeruginosa forms biofilms
on surfaces through a highly coordinated process of initial attachment, maturation, and
dispersal. An exopolymeric substance (EPS - eDNA, proteins, lipids, carbohydrates)
covers the cells and reduces the penetration of chemicals into the biofilm. By encasing
the bacteria in an exopolymeric shield and reducing cellular activity, biofilms increase
antibiotic resistance up to 1000x compared to planktonic cultures [31]. Another
resistance feature is differentiated cells with more active cells closer to the surface and
dormant cells closer to the core. Dormant cells naturally resist antibiotics because those
drugs often target active processes in bacteria, which are reduced within the biofilm [32,
13

33]. Biofilms also contain small colony variants, which are highly antibiotic resistant
when compared to planktonic cells [34]. Bacteria form biofilms or macrocolonies in
response to the host environment; therefore, bacterial infections naturally contain
resistance mechanisms that may be only controlled by a functioning immune system [35,
36].
Although not completely understood as an antibiotic resistance mechanism, P.
aeruginosa contains a large genome, > 6Mb, which allows the bacteria to have
specialization and redundancy within essential systems [37]. Apart from the large
genome, >9% of the genes encode for regulatory systems that provide metabolic diversity
and quick adaptation to an environment [38]. An example is the P. aeruginosa
redundancy of key systems such as the Pel or Psl systems to produce polysaccharides for
different components of the biofilm [39]. When one system is chemically inhibited, such
as the Pel polysaccharide system, then another system, the Psl polysaccharide system, is
able to perform the same function to help the bacterium survive [40]. To this end, true
biocidal targets of P. aeruginosa may be difficult to identity because essential targets
may not be easily found.
Acquired mechanisms of antibiotic resistance include those via transduction and
transformation of DNA from the environment. Extracellular DNA from diverse bacterial
sources can code for resistance mechanisms that are taken up and expressed. Those
bacteria possessing the resistance mechanism will then pass on the gene to future
progeny. P. aeruginosa strains that have acquired metallo-β-lactamases have been found
to cause hospital-wide outbreaks and, in general, are difficult to control [41]. Another
acquired mechanism, which doesn’t require acquisition of extracellular DNA, is the
14

process of generating DNA-damaging reactive oxygen species (ROS) [42]. Damaged
DNA can be repaired, but often at the expense of mutations that generate new phenotypes
expressed within the bacterial population. P. aeruginosa metabolism, phenazines, and
certain alkylquinolones generate ROS in the environment. ROS-damaged DNA within
genes such as RecA may result in different bacterial phenotypes due to the loss of a
global regulator [43]. The ability to actively promote DNA mutations under stress, known
as the “Insurance Hypothesis”, generates new phenotypes that are optimal in certain
environments [43].
Traditional antibiotic treatments target essential cellular structures and functions
such as the cell wall and protein synthesis. Therefore, antibiotics place a selective
pressure on bacterial communities for those that can survive the treatment. Drug-resistant
mutants pass on the mutation through horizontal and vertical gene transfer leading to
widespread antibiotic resistance. In order to subvert the selection of resistance mutants, a
new approach to treatment should target bacterial mechanisms such as virulence factor
production or biofilm formation that are not essential for growth. This strategy would
reduce the selective pressure of targeting those bacteria that are susceptible and place
more emphasis on the immune system to naturally clear an infection. Bacterial
communication, which is dispensable for growth, is one such target for anti-virulence
because of its link to virulence factor regulation and community behaviors.
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1.3 Bacterial quorum sensing

In order to colonize a new environment or cause an infection, P. aeruginosa
communicates through chemical messaging systems to coordinate collective phenotypes
[44-46]. Communication between bacteria, known as QS, provides a mechanism to
determine the cell density and composition of the bacterial community. Although
community behaviors have been widely notice by microbiologists, the first published
study of QS was determined from Vibrio fischeri and its symbiotic behavior with the
Hawaiian Bob-Tailed squid [47]. In the light-organ of the squid, bacteria produced light
only in high densities following replication throughout the day. Further work found that a
small molecule and a novel two-component system regulated the light system. Following
the initial discovery of light generation, QS was determined to regulate community
phenotypes such as biofilm formation, swarming motility, and the production of
virulence factors. QS mutants are unable to establish effective infections and have been
isolated from sites of bacterial infection (discussed in a later section).
Instead of the planktonic cultures that were traditionally envisioned, QS provides
the ability to act as a higher multicellular organism. Interestingly, cells within the
community share public and private goods [48]. Communication via QS arranges a
mechanism to differentiate roles within a community, synchronize specific phenotypes,
and regulate mutants that arise in the system [49]. Differentiated cells can display altered
secondary metabolite synthesis, metabolism, virulence factor production, and DNA
transformation [50]. Synchronization of phenotypes provides temporal regulation so that
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bacteria can regulate the production of virulence factors or other secondary metabolites
only when they are needed [51]. This ‘timed-regulation’ can save energy and resources.
Bacteria communicate by secreting small signaling molecules into the
environment. To this end, the concentration of the signaling molecules increases with cell
density. Consequently, increasing extracellular concentration drives QS molecules back
into the cell by diffusion. Once the intracellular concentration of a QS molecule reaches a
threshold, the QS molecule activates a cognate transcriptional regulator to enact changes
in transcription [52]. In order to prevent early activation of the transcriptional regulators,
orphan transcriptional regulators bind specific QS molecules and reduce the available
intracellular concentration of QS molecules [53]. QS system regulation is also
accomplished through limiting precursors incorporated into the QS molecules. In order to
retain some QS molecules that have been secreted, biofilms utilize the constituents of the
EPS to transiently interact with the QS molecules so that those molecules remain with the
biofilm [54]. This polymer greatly reduces the loss of secreted metabolites and also
provides more intimate signaling opportunities.
Apart from cellular density, environmental stimuli can also affect QS systems
[21]. For example, low iron and phosphate activate the necessary QS systems, which
induce extracellular systems responsible for gathering essential nutrients [55, 56].
Oxygen concentration has also been shown to have a relationship between QS and
metabolism in P. aeruginosa [57]. Specifically, low oxygen concentrations affect the
nitrate reductase system, which subsequently down-regulates the Pqs system. Stress
response is another environmental factor that can alter QS [58, 59]. P. aeruginosa utilizes
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the RelA-SpoT stress response system to produce the alarmone ppGp(p), which
selectively activates the different QS systems [60].
Quorum-sensing molecules exhibit either broad or specific activity (Fig. 1.1).
Bacteria universally produce Auto-inducer-2 (AI-2), but the individual receptors for the
QS molecule have only been studied in a few species. Small cyclic peptides synthesized
from Gram-positive bacteria target various two-component adaptive response proteins to
regulate competence, sporulation, and virulence factor production [61, 62]. Acylated
homoserine lactones (HSL) are conserved among Gram-negative bacteria and target
LuxR-type transcriptional regulators [63]. HSL systems regulate certain community
phenotypes, production of virulence factors, and acquisition of nutrients. Finally, some
bacteria possess novel QS systems that are only shared among related species. P.
aeruginosa produces alkylquinolones, which are conserved only to closely related
Burkholderia species. Bacteria that contain these novel QS systems can use their own
language to control certain processes that may not be intercepted by other bacteria. To
date, P. aeruginosa produces AI-2, two separate acylated-homoserine lactones, and a
diverse group of alkylquinolones. Current work has also identified other non-canonical
QS systems that are environment-specific [64, 65].
QS molecules also play roles apart from signaling. In Gram-positive bacteria such
as Staphylococcus aureus, the small signaling peptides have potent antibiotic properties.
An example from Gram-negative bacteria, extracellular homoserine lactones and
alkylquinolones from P. aeruginosa antagonize the host immune response during an
infection [66]. Further explanation of alkylquinolones as multifunctional molecules will
be discussed in another section (1.5).
18

Figure 1.1 Diversity of QS molecules produced from bacteria.
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1.4 Major quorum-sensing systems in P. aeruginosa

In P. aeruginosa, there are three commonly studied QS systems; the Las, Rhl, and
Pqs systems (Fig. 1.2). These QS systems control community phenotypes such as
swarming, biofilm formation, and virulence factor production [67]. During replication to
higher cellular densities, the QS systems function together in a hierarchal manner [68,
69]. The Las system, which is initiated earliest during growth, produces 3-oxo-C12Homoserine Lactone (C12-HSL) and activates the LasR transcriptional regulator. An
activated Las system synthesizes a protease and also induces the other QS systems [45,
70]. The Rhl system produces C4-Homoserine Lactone (C4-HSL) and activates the
transcriptional regulator RhlR [58]. The Rhl system regulates the production of
rhamnolipids, which aid in swarming and absorption of hydrophobic compounds [71, 72].
Secreted rhamnolipids also initiate apoptosis in neutrophils and reduce ROS in the
environment [73]. Following a transposon mutant screen for genes regulated by the Las
system, the Pqs system was discovered to be a novel system compared to traditional
Gram-negative QS [74]. The Pqs system produces alkylquinolones that activate the
transcriptional regulator PqsR (also known as MvfR). Signaling from the Pqs system
controls production of virulence factors, iron chelators, and biofilm formation [75, 76].
Together, these three QS systems function together to control up to 12% of the genome
and are essential for survival and community phenotype regulation [77, 78].
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Figure 1.2 Interconnected QS systems in P. aeruginosa. Three core QS systems are
both positively and negatively regulate each other. As bacterial density increases, there
is a shift from Las-mediated transcriptional regulation to Rhl and Pqs transcriptional
regulation.
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Hierarchy of the QS systems in P. aeruginosa guides the production of virulence
factors and community development in a new environment [21]. After initial growth, C12HSL signaling activates production of proteases that degrade peptides in the environment
and affects host cell integrity [79]. The Las system also regulates biofilm formation
following initial attachment to a surface. After Las system activation, the Rhl system
participates in biofilm formation by forming water channels within the biofilm and also
helps to secure fatty acids from the environment [80]. Rhamnolipids also block attack by
the host immune system and participate in infiltration of airway epithelial cells [81]. The
Pqs system contributes to biofilm formation by providing eDNA via autolysed cells and
increases the production of virulence factors such as pyocyanin, hydrogen cyanide, and
lectins [82, 83]. During an infection, the cascade of QS systems alters host immune cell
reaction to bacteria, forms biofilms, and secures limited nutrients within the environment.
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1.5. The Pseudomonas quinolone signal (Pqs) system

P. aeruginosa culture supernatants contain greater than fifty different quinolone
molecules that vary in alkylation and modification on the quinolone ring [84]. Three
alkylquinolones have garnered most of the attention for research; specifically, 2-heptyl-4quinolone (HHQ), 4-hydroxy-2-heptylquinolone N-oxide (HQNO), and 2-heptyl-3,4hydroxy-quinolone (PQS) [76]. Most of the other unmentioned quinolones exist in low
concentrations and do not have specified function. Contrary to the HSLs, the quinolone
ring is stable in different environments, but is affected by certain ring-hydrolyzing
enzymes [85]. Those enzymes responsible for breaking down quinolones are not found in
humans, which may allow quinolones to persist in the chronic wound environment for
long periods of time.
The Pqs system consists of a transcriptional regulator, PqsR, and a five-gene
operon, pqsABCDE (Fig. 1.3). Only Burkholderia thailandensis and Burkholderia
pseudomallei possess homologous biosynthetic operons for quinolones, while no other
Pseudomonas species use quinolones as a mechanism for QS [86]. PqsR belongs to the
LysR-type transcriptional regulator family, which are structurally and functionally
diverse DNA-binding proteins [87]. PqsR contains two domains; the C-terminus ligandbinding domain and the N-terminus DNA-binding domain. Crystal structures of PqsR
bound to C9-PQS and a PQS-analogue identified two hydrophobic pockets that
coordinate binding with the quinolones [88]. The peripheral hydrophobic pocket on the
protein associates with the alkyl-moiety, while the interior pocket forms hydrogen bonds
with the hydroxyl-groups and the hydrogen on the quinolone ring.
23

Anthranilic acid, a precursor for tryptophan and quinolone synthesis, is formed
from chorismate along with the enzymes PhnA and PhnB [89]. Three separate systems
monitor anthranilic acid levels in the cell, which indicate the importance of this precursor
to P. aeruginosa for maintaining a cellular pool to synthesize phenazines, catechol,
tryptophan, and quinolones [90].
For quinolone synthesis, PqsA modifies anthranilic acid to form anthraniloylCoA, of which the product subsequently interacts with PqsD [91]. Following binding,
CoA is released and a fatty acid is brought into the PqsD catalytic site for condensation
with the anthranilate [92]. DHQ, the only terminate non-alkylated quinolone, is
synthesized by PqsD from anthranilate and malonyl-CoA [93]. Alkylquinolone synthesis
requires anthranilate condensation with longer-chain fatty acids such as β-keto fatty acid
or octanoic acid and malonyl-CoA [94]. Condensation using PqsD, PqsB and PqsC form
the initial alkylquinolone, HHQ. PqsD, PqsC, and PqsB share similar sequence homology
and are described as FabH-type condensing enzymes [93]. However, PqsD is the only
enzyme that contains the complete catalytic triad, Cys-His-Asn. Until recently, PqsE was
not thought to participate in quinolone synthesis, but rather regulate the production of the
virulence factor pyocyanin [95]. New data from Drees et al has now shown that PqsE
may also be functioning as a thioesterase to increase precursors for alkylquinolone
synthesis [96].
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Figure 1.3 Synthesis and regulation of quinolones from the Pqs system. The
red arrow indicates an undiscovered role for DHQ.

25

The pqs operon produces DHQ and HHQ, whereby HHQ is subsequently
modified to generate other quinolones. PqsH synthesizes PQS, which adds a second
hydroxyl-group to HHQ using oxygen [97]. Other pqs enzymes, such as PqsS and PqsL,
are coded elsewhere on the genome and also modify the alkylquinolones [76].
Quinolone production can be expensive to the cell due to the requirements for
precursors from fatty acid pools and anthranilic acid. However, P. aeruginosa requires an
intact Pqs system to cause an infection [82, 98]. Quinolones play diverse roles for P.
aeruginosa, but there are still several unanswered questions; specifically, the complete
mechanism of quinolone synthesis and the function of a diverse set of quinolones.
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1.6 Roles of the quinolones

Quinolones play both intracellular and extracellular roles for P. aeruginosa
virulence, while only HHQ, HQNO, and PQS have established functions. HQNO is an Noxide form of HHQ that is toxic towards Gram-positive bacteria [99]. HHQ performs
similar functions compared to PQS, but is found at significantly lower concentration
because it is a precursor for PQS that is actively turned over under aerobic conditions
[84]. The major effector of the Pqs system is PQS (Fig. 1.4). As a signaling molecule,
PQS regulates biofilm formation, swarming, and extracellular functions to control the
environment [100, 101]. PQS signaling is also responsible for activating the Rhl operon,
which synthesizes rhamnolipids that coat the surface and reduce the co-efficient of
friction for swarming. Extracellular PQS can initiate cellular autolysis, which adds eDNA
to the exopolymeric substance for biofilm formation and may have undiscovered roles in
the PQS-laden blebs from the membrane [102, 103].
PQS-activated PqsR controls the production of virulence factors such as
pyocyanin and hydrogen cyanide [98]. Pyocyanin, the characteristic blue-green pigment
of P. aeruginosa, is a redox-active molecule that forms an electrocline surrounding a
biofilm [104]. Due to its electrogenic potential, pyocyanin kills both eukaryotic and
prokaryotic cells by creating reactive oxygen species [105]. Hydrogen cyanide has not
been quantified from the environment during P. aeruginosa colonization, but was
elucidated by infecting a model species with the bacterium [82]. Therefore, regulation of
PqsR through PQS provides P. aeruginosa with an arsenal of virulence factors to unleash
during infection.
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Figure 1.4 PQS is a multifunctional molecule and participates in several aspects
of P. aeruginosa pathogenicity. PQS also functions to maintain P. aeruginosa
within an environment and secure limiting nutrients.
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Secreted PQS and HHQ antagonize immune cell signaling from host cells.
Alkylquinolones inhibit the NF-ĸB pathway in macrophages causing a reduction in both
IL-6 and TNF-α [106, 107]. PQS also blocks T-cell proliferation, which is important for
the adaptive immune response by inhibiting dendritic cell antigen presentation [108].
Overall, control of the immune response is an important contribution to the ability of P.
aeruginosa to cause chronic infections.
A unique trait to PQS is the sequestration of iron from the environment [109]. P.
aeruginosa produces several iron siderophores, which trap iron from the environment
[110, 111]. Three PQS molecules bind a single iron ion in the environment and reduce its
availability to other organisms [109, 112]. It was proposed that PQS sequesters iron at the
membrane of P. aeruginosa in order to increase the efficiency of siderophores [112].
Other quinolones possess similar structure, but do not appear to have the same ability to
chelate. Although PQS has established chelation activity, further research is needed to
understand the potential role of PQS-iron interactions during an infection.
Extracellular roles of the quinolones show how P. aeruginosa optimizes
production of molecules for not only signaling, but also controlling the environment.
However, most of the extracellular functions were elucidated using in vitro conditions
and have not been demonstrated during an infection. Apart from pathogenicity, there are
several links to quinolones and metabolic pathways. However, the metabolic flux from P.
aeruginosa remains to be elucidated in conditions that represent an infection.
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1.7 Mechanism of DHQ synthesis

Alkylquinolones HHQ and PQS have been extensively studied for their functions
in P. aeruginosa pathogenicity. Critically, HHQ and PQS activate PqsR for
transcriptional regulation of virulence factors and also provide extracellular functions. Of
the quinolones produced, DHQ is the most abundant in P. aeruginosa planktonic culture
[93, 113]. DHQ requires anthranilic acid, malonyl-CoA, and the enzymes PqsA and PqsD
for its synthesis, which is significantly shortened compared to alkylquinolone synthesis.
Given the truncated mechanism, increased DHQ synthesis is also perpetuated through
more abundant precursors and no requirement for oxygen from the environment [114].
Because it has its own synthesis mechanism, DHQ is neither a precursor nor a
degradation byproduct from the alkylquinolones, which highlight this molecule as unique
and may play a novel role for the Pqs system.
Liquid chromatography and mass spectrometry can be used to quantify the
different alkylquinolones from culture supernatant (Fig. 1.5). Supernatant from a pqsA
KO-strain did not resolve any quinolone production. To identify mutants that altered
DHQ synthesis, radiolabeled anthranilic acid was fed to wild-type and pqs mutants (Fig.
1.6). Following incubation of the pqs mutant strains, supernatants from the cultures were
processed using TLC and monitored by autoradiography. Mutants of pqsB and pqsC
maintained DHQ production, but did not produce the alkylquinolones. Mutants of pqsA
and pqsD did not produce any quinolones, which indicated they were essential for all
quinolone synthesis. The function of PqsA and PqsD for DHQ synthesis was confirmed
in an E. coli strain, which maintained DHQ production using a plasmid containing both
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pqsA and pqsD. DHQ production was also demonstrated in vitro with purified PqsA and
PqsD. Both of the precursors, malonyl-CoA and anthranilic acid, sufficed for DHQ
synthesis, while only activated forms of malonate were incorporated.
Virulence associated with DHQ production was initially visualized through inhibition of
the yeast Cryptococcus neoformans (Cn) from a pqs mutant that was only capable of
synthesizing DHQ [115] (Fig. 1.7). However, the DHQ-only mutant did not inhibit
growth to the same degree compared to the wild-type. To determine toxicity towards host
cells, DHQ was also incubated with mouse lung epithelial cells. DHQ treatment reduced
epithelial cell number in a time-dependent and concentration- dependent manner [93].
These results demonstrated that the production of DHQ was associated with virulence
factor production and induced extracellular effects.
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Figure 1.5 LC-MS trace of quinolones in P. aeruginosa supernatant. In
wildtype supernatant, DHQ was the most abundant quinolone, followed by the
alkylquinolones. From the pqsA mutant supernatant, no quinolones were
quantified.
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Figure 1.6 Mutants of the pqs operon displayed differences in synthesizing
DHQ and the alkylquinolones. Only wild-type, pqsB, and, pqsC maintained
production of DHQ, while pqsA and pqsD were devoid of quinolone
production.
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Figure 1.7 Pyocyanin negatively affects growth of yeast Cryptococcus neoformans.
Lawns of C. neoforms were challenged against filter disks containing culture
supernatant from P. aeruginosa PAO1 and pqs mutants. Pyocyanin from the P.
aeruginosa strains were measured in vitro in normal laboratory conditions.

34

CF patients can harbor P. aeruginosa in their lungs for years. Therefore, CF
patient sputum may contain secreted molecules that have accumulated over time. PQS
has been quantified from sputum samples using various methods, while the composition
of quinolones from the samples has not been assessed [116, 117]. Other studies of P.
aeruginosa QS molecules from sputum have focused on the homoserine lactones. Struss
et al. quantified the long chain HSL, 3-oxo-C12-HSL, and identified an increasing trend in
concentration prior to admission for an exacerbation and a decreasing trend following
admission [118]. However, concentration of 3-oxo-C12-HSL rebounded back to the levels
found during stable disease after a week of IV antibiotic therapy. To date, no study to
date has investigated all of the major QS molecules from P. aeruginosa and how the
composition of the molecules may be related to disease severity. Because QS regulates
virulence factor production and community behaviors, composition of QS molecules may
predetermine certain negative events such as declining of lung function or an
exacerbation. Also lacking are studies of quinolone composition on the basis of CF
mutation, current antibiotic/lung-clearing therapy, and other cultured microorganisms.
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1.8 Hypothesis and Specific Aims

The short-term goals of this study are to understand how DHQ production is
involved in P. aeruginosa pathogenicity, the activity of DHQ with the transcriptional
regulator PqsR, and dynamics of DHQ concentration in CF patient samples. Our longterm goal is to understand the fitness provided by DHQ production and its effect on
chronic colonization of P. aeruginosa. No group has published a function for DHQ, only
its high concentration in culture. Compared to PQS, DHQ does not require oxygen, which
is especially limited within biofilms and the mucus of CF patients [119, 120]. Finally,
DHQ possesses a similar structure compared to the alkylquinolones, which may allow for
similar interactions with PqsR. The high concentration of DHQ warrants investigation
into the extracellular effects against host cells. Overall, further understanding of the Pqs
system makes it a good target for inhibition, but it is also important to understand the
roles quinolones play during an infection to successfully block the communication
system.

Hypothesis: DHQ plays a role in P. aeruginosa pathogenicity as a ligand for
PqsR and controls host cell functions.

Specific Aim 1: Determine effect of DHQ production on P. aeruginosa
pathogenicity. Alkylquinolones HHQ and PQS play a role in transcriptional regulation
as ligands of the transcriptional regulator PqsR. Extracellular HHQ and PQS also exhibit
anti-inflammatory effects. We infer DHQ plays a similar role in pathogenicity during an
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infection, but may have specialized functions within certain environments. To investigate
the mechanism of DHQ on virulence, we propose the following sub aims: 1) determine
virulence associated with DHQ production; 2) determine effect of growth environment on
synthesis and secretion of DHQ; and 3) determine effect of DHQ on eukaryotic cells. We
will use established methods for Caenorhabditis elegans infection to estimate total
pathogenicity and quantify in vitro virulence factor production. We will also develop a
model of C. elegans to investigate bacterial colonization in real-time. Liquidchromatography with mass spectrometry (LC-MS) will be used to quantify DHQ and
other QS molecules from samples. We will assess quinolone composition under the
following conditions: in LB and cystic fibrosis mimic media (CFMM) using aerobic and
anaerobic conditions. Finally, we will test the effect of DHQ on eukaryotic cells for
viability and cytokine analysis by enzyme-linked immunosorbant assay (ELISA).

Specific Aim 2: Determine effect of DHQ on PqsR for activating
transcription of the pqs operon. HHQ and PQS activate PqsR to bind to the upstream
regulatory site of the pqsA promoter. Transcription of the operon not only leads to
virulence factor production, but also leads to further production of the quinolones by
generating a positive feedback loop. To determine the role of DHQ on PqsR activation,
we propose the following sub-aims: 1) determine the activity of DHQ on transcription of
the pqs operon through PqsR; and 2) determine kinetic interaction of PqsR with DHQ.
For these aims, we will quantify expression of pqsA in wild-type and pqs mutants using
RT-PCR. We will also use a pqsA’-LacZ fusion reporter assay in P. aeruginosa strains
and E. coli supplemented with exogenous quinolones. For the protein-ligand interaction
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studies, we will use saturation transfer difference NMR (STD-NMR) that will identify the
specific interactions of DHQ in the binding pocket of PqsR. Electrophoretic mobility
shift (EMSA) in vitro assays will show the influence of DHQ on PqsR binding to the
promoter region of pqsA.

Specific Aim 3: Determine DHQ concentration and composition of
quinolones in CF sputum during stable and exacerbated disease states. Little is
known about the dynamics of P. aeruginosa QS molecules during CF disease
progression, especially since there are limited publications that report QS molecules in
sputa. QS molecules provide a link to both bacterial density and virulence, which may be
important in interpreting in vivo phenotypes. DHQ has not been quantified from CF
sputum; however, PQS and homoserine lactones were previously identified in patient
samples. Given that DHQ is secreted by P. aeruginosa in high concentrations in vitro, we
predict that DHQ will be readily identified in both stable and exacerbated samples. The
role of P. aeruginosa to initiate an exacerbation is not known, although declining lung
function may be accompanied by increased colonization and density. To investigate the
composition of quinolones during different disease states in CF patients, we propose the
following sub-aims: 1) determine QS molecule composition in stable CF patients and
compare concentrations based on patient CFTR mutation, antibiotic treatment, lung
volume, and organisms cultured from samples; and 2) determine QS molecule
composition during an exacerbation compared with stable levels. We will initiate a
patient study of adult CF patients colonized with P. aeruginosa to obtain sputum samples
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from clinic visits and hospitalized patients. QS molecules extracted from sputum will be
quantified using LC-MS.
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Chapter 2: Role of DHQ in P. aeruginosa pathogenicity and extracellular effects
against host cells.
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2.1 Introduction
P. aeruginosa possesses a versatile metabolic system, which allows the bacterium
to live in diverse soil and aquatic environments. People frequently come into contact with
P. aeruginosa, but an intact immune system can block the bacterium from establishing an
infection. However, immunocompetent and immunocompromised patients are still at risk
for infection, particularly those who have diabetic or burn wounds, undergo surgery for
an implantable device, or use contact lenses [121-124]. Patients with the genetic disorder
cystic fibrosis (CF) are highly susceptible to P. aeruginosa infection, which is correlated
with increased mortality [19, 125]. In CF lungs, P. aeruginosa replicates to high densities
and forms antibiotic-resistant biofilms, a community lifestyle protected by exopolymeric
substance [23, 126]. Treatment of chronic and acute P. aeruginosa infections is
complicated due to numerous endogenous antimicrobial resistance mechanisms,
including reduced outer-membrane porin size, increased expression of efflux pumps, and
high mutation rate [127, 128].
Quorum sensing (QS) synchronizes group behaviors and is essential for P.
aeruginosa to establish an infection [46]. The act of QS is comprised of releasing and
uptake of signaling molecules that activate cognate transcriptional regulators at a critical
intracellular concentration. Each QS system plays a role in community phenotypes and
virulence factor production [74, 129-131]. The Las and Rhl systems, conserved to Gramnegative bacteria, produce acyl-homoserine lactones that activate cognate LuxR-type
transcriptional regulators, LasR and RhlR [130, 132]. The Pqs system, conserved to P.
aeruginosa, Burkholderia thailandensis, and Burkholderia pseudomalia, produces
alkylquinolones that activate a LysR-type transcriptional regulator, specifically, PqsR in
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P. aeruginosa [86, 133]. Few quinolones have established functions for signaling,
controlling the microenvironment, and facilitating biofilm formation; however, greater
than 50 different quinolones are produced from the Pqs system [84, 133, 134].
Alkylquinolones are synthesized from the pqs operon and associated genes
located elsewhere on the genome. The first step in quinolone synthesis requires PqsA to
convert anthranilic acid, an intermediate of tryptophan biosynthesis, to anthraniloyl-CoA
[91, 113]. The next step involves the transfer of the anthraniloyl-moiety to PqsD and the
release of CoA [92]. Using simulations and surface Plasmon resonance, PqsD and the
substrates display a ping-pong type mechanism, which is in agreement with other Claisen
condensing enzymes [135]. PqsD condenses the anthraniloyl moiety with malonyl-CoA
to form DHQ, the only terminate, non-alkylated quinolone species [93]. Formation of
HHQ requires PqsD, PqsB, and PqsC to condense longer chain fatty acids with
anthraniloyl-CoA [76]. PqsH converts HHQ to PQS in the presence of oxygen [97].
Unsaturations, variation in the length of the alkyl chain, and modification of the ringsubstituted nitrogen generate the diversity of alkylquinolones [136, 137]. PQS and HHQ
activate PqsR to initiate a positive-feedback mechanism that increases transcription of the
pqs operon and further quinolone production [138, 139]. Among the genes regulated by
PqsR for virulence, PqsE controls the production of pyocyanin, a potent redox-active
virulence factor, through an unknown mechanism [75].
PQS plays numerous roles in P. aeruginosa pathogenicity [76, 137]. However, P.
aeruginosa frequently colonizes hypoxic zones within CF lungs, which may reduce PQS
production due to lack of oxygen [140, 141]. Deep sequencing has allowed for the
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detection of anaerobic bacteria within the lungs of CF patients indicating the lack of
oxygen found in certain parts of the lungs [142].
In comparison to other quinolones produced from the Pqs system, DHQ is the
most abundant in P. aeruginosa planktonic cultures. DHQ also shares a similar structure
with the alkylquinolones, which provides rationale in that DHQ functions similar to other
established quinolones [93, 113]. Therefore, based on the high cellular expense of
anthranilic acid to produce DHQ and numerous roles played by alkylquinolones to
establish an infection, we hypothesize DHQ plays an important role in P. aeruginosa
pathogenicity, potentially under hypoxic conditions. In this study, we investigated the
role of DHQ on P. aeruginosa virulence, production of DHQ in different environments,
and effect on epithelial cells and macrophages.
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2.2 Results
Production of DHQ increased P. aeruginosa virulence in the C. elegans infection
assay. In order to delineate function of DHQ from the other quinolones, we produced
non-polar mutants of the pqs operon using the common lab strain PAO1 (originally
isolated from a burn wound). Knockout of pqsAB resulted in abolished quinolone
production, while knockout of pqsB or pqsC resulted in mutants that only produced
DHQ. Previous results have indicated wild-type PAO1 required both virulence factor
production and the ability to colonize the nematodes in order to kill C. elegans following
several days of incubation (>200 h) [143-147]. We monitored the survival of C. elegans
infected with PAO1 and pqs mutants to determine a role DHQ may play (Fig 2.1) [148].
None of the nematodes survived infections from PAO1, ΔpqsB, and ΔpqsC after 220 h of
incubation, while 50% of the nematodes infected with ΔpqsAB remained viable. The
reduction in virulence from the ΔpqsAB mutant was attributed to loss of quinolone
production. In comparing survival trends, C. elegans survival incubated with PAO1
displayed the sharpest downward trend compared to the other strains. PqsB and PqsC are
both essential for alkylquinolone synthesis but are not required to produce DHQ.
Compared to the ΔpqsAB mutant, the trend of C elegans killing by the ΔpqsB and ΔpqsC
decreased faster over time and also indicated that DHQ production maintained the same
level of virulence in both mutants. Altogether, the survival trends demonstrated that
production of DHQ was related to increased pathogenicity towards a model of bacterial
infection.
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Figure 2.1 Survival of C. elegans infected with PAO1 and pqs mutants. P. aeruginosa
strains were incubated with C. elegans and worm survival was monitored daily for over 10
days. Each assay contained around 30 nematodes per strain and was performed in triplicate.
Survival data of all of the assays were combined and plotted in a Kaplan-Meier survival
curve and analyzed using the Log-Rank test (significant * p = 0.05, ** p<0.05,
***p<0.0001).
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None of the nematodes survived infections from PAO1, ΔpqsB, and ΔpqsC after
220 h of incubation, while 50% of the nematodes infected with ΔpqsAB remained viable.
The reduction in virulence from the ΔpqsAB mutant was attributed to loss of quinolone
production. In comparing survival trends, C. elegans survival incubated with PAO1
displayed the sharpest downward trend compared to the other strains. PqsB and PqsC are
both essential for alkylquinolone synthesis but are not required to produce DHQ.
Compared to the ΔpqsAB mutant, the trend of C elegans killing by the ΔpqsB and ΔpqsC
decreased faster over time and also indicated that DHQ production maintained the same
level of virulence in both mutants. Altogether, the survival trends demonstrated that
production of DHQ was related to increased pathogenicity towards a model of bacterial
infection.
Fluorescence-producing bacteria have been used to infect C. elegans in order to
study the internalization of bacteria and their localization in different tissues [149]. To
visualize colonization of C. elegans by the P. aeruginosa strains, we monitored
nematodes infected with PAO1 and the pqs mutants carrying a plasmid that constitutively
expressed GFP (Fig 2.2) [150]. After 4 h of co-incubation, GFP-expressing bacteria was
present in the nematodes after 4 hours of incubation on the bacterial lawns. After 24 h,
GFP-expressing bacteria were distributed throughout the intestinal tract of all the
nematodes investigated. There was no overall qualitative difference between bacterial
accumulation comparing the 4 and 24 hour time point. At 144 h, C. elegans infected with
PAO1 and ΔpqsB showed higher GFP fluorescence than those infected with the ΔpqsAB
mutant. Colonization was observed throughout 75% of the length of the nematodes that
had been incubated with those strains.
46

Figure 2.2 Real-time monitoring of C. elegans infected with P. aeruginosa
strains expressing GFP. C. elegans were incubated on plates containing P.
aeruginosa, which constitutively expressed GFP. At the indicated times, C.
elegans was investigated for fluorescence at 435nm excitation and 485nm
emission. Assay was completed in triplicate. Pictures shown were from the
same assay. GFP fluorescence was quantified using ImageJ and graphed.
Samples at 144 h were statistically compared using the student' t-test (* p <
0.05).
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Because of the disparity of fluorescence, we determined the difference in bacterial
colonization by comparing fluorescence of the strains following 1 second of excitation
versus 5 seconds of excitation. A 5 second excitation yielded oversaturated fluorescence
when analyzing nematodes infected with PAO1 and the ΔpqsB mutant, while minimal
fluorescence was detected from those infected with ΔpqsAB. A 1 second excitation
resolved the oversaturation in PAO1 and ΔpqsB infected nematodes and demonstrated
only background fluorescence from nematodes infected with the ΔpqsAB mutant. The
144 h time point was important to show because it coincided with a sharp decrease in C.
elegans survival among the nematodes infected PAO1 and ΔpqsB.
Over the course of an infection, P. aeruginosa displays several successive steps in
order to establish itself with the nematode. In our study, following several hours of
incubation, PAO1 and ΔpqsB both showed tissue invasion from the central gut-tract and
into the intestines and some gonadal tissue. The actions taken by the P. aeruginosa
strains appear to be initial attachment to the host tissue, protection from host antiinfection mechanisms, and breakdown of tissues to move away from the central gut-tract.
Although fluorescence microscopy only visualized bacteria in different tissue sections of
the nematodes, comparison of the different strains indicated that those able to produce
DHQ maintained a similar infection progress compared to the wild-type.
Along with colonization of C. elegans, virulence factor production is also
important for nematode killing. Pyocyanin, a blue-green redox-active pigment, is a potent
virulence factor that is toxic towards other microorganisms and eukaryotic cells [115,
151-153]. Pqs enzymes PqsR and PqsE participate in the regulation of pyocyanin
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production. PqsR activates transcription of the phz operon, but the role of PqsE in
pyocyanin production is not understood [154].
To demonstrate that changes in virulence were not due to defects in growth, we
found all of the strains grew similarly regardless of their mutation (Fig 2.3). Next, we
quantified pyocyanin from overnight cultures of PAO1 and pqs mutants grown in LB
media. PAO1 produced the highest amount of pyocyanin followed by the ΔpqsB mutant.
The ΔpqsAB mutant produced the least amount of pyocyanin. LB media is a rich media
that contains an excess amount of nutrients to support high-density growth of bacteria.
The media alone may help to potentiate pyocyanin production because of the low level
found in ΔpqsAB mutant culture. However, this media does not represent of the
environment colonized by bacteria during an infection. Nutrient conditions alter the
bacterial phenotypes expressed; thereby, bacteria grown in LB compared to a less
nutrient-dense media may demonstrate different phenotypes [155]. Therefore, we tested
how growth in media more representative of an infection environment, cystic fibrosis
mimic media (CFMM), would affect pyocyanin production. CFMM was chemically
defined by LC-MS to quantify the abundance of carbon and nitrogen sources from cystic
fibrosis sputa. Although the overall concentrations were lower, we found a similar trend
in pyocyanin production among the strains compared to LB. Because of the loss of
pyocyanin from the ΔpqsAB mutant, this demonstrates the requirement for quinolone
production in the context of an infection.
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Figure 2.3 Growth and pyocyanin production by PAO1 and pqs mutants. (A) Growth
curves of P. aeruginosa strains in LB over 24 h. (B) Pyocyanin was extracted from 18
h planktonic cultures grown in LB and quantified spectrophotometrically at 520 nm.
(C) Growth curves of P. aeruginosa strains in SCFM over 24 h. (D) Pyocyanin was
extracted from 24 h planktonic cultures grown in SCFM and measured the same as in
LB. Experiments were performed in triplicate. C,D data is represented as box-andwhisker plots with the mean and range of the data. The data was statistically analyzed
using a Student's T-test (** p<0.005, *** p < 0.0001).
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Because pyocyanin production is regulated by Pqs signaling, we wanted to
investigate if exogenous DHQ can rescue pyocyanin in the quinolone-null mutant.
Culture supernatants from the different strains contain the quinolones in their natural
form following secretion. Quinolones are not soluble in aqueous solutions; however,
other secreted molecules may help solubilize the QS molecules. For the add-back
experiments, we supplemented culture supernatants of the P. aeruginosa strains to
ΔpqsAB cultures and incubated overnight. PAO1 and ΔpqsB supernatant supplied to the
ΔpqsAB mutant rescued pyocyanin production, while the ΔpqsAB mutant with ΔpqsAB
culture supernatant had little effect. Supplementation of pure DHQ back to the ΔpqsAB
did not affect pyocyanin production, which indicated DHQ may have poor solubility in
solution and/or require another factor to help cross the membrane. Overall, the
importance of PqsR activation by the quinolones is underscored by the loss of pyocyanin.
The Pqs system activates both the Las and Rhl systems. Therefore, the effect of
DHQ production apart from other quinolones on the concentration of virulence factors
from the Las and Rhl systems are important to determine. Elastase and rhamnolipids are
secreted from the cell and can be quantified from the culture supernatant. In the same
growth conditions used for assessing pyocyanin production, production of DHQ did not
significantly affect other virulence factor production (Fig 2.4). This result was surprising
given the interconnected relationship of the QS systems found with PQS. The effect of
the Pqs system on the other QS systems may need to be assessed during a time-course,
which could resolve changes between the mutants.
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Figure 2.4 Elastase and rhamnolipids quantified from the P. aeruginosa strains grown
in LB and CFMM. Samples were extracted from culture supernatants and measured at
the indicated OD. Samples were measured in triplicate and the average and the error
bars represent the standard deviation.
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To date, long-term monitoring of the phenotypes from the QS systems has not
been published. Biochemical modeling of the QS systems has indicated a circadian
rhythm between activation of the Rhl system and the Pqs system, but has not been shown
experimentally.
DHQ was the most abundant extracellular quinolone produced during
aerobic and anaerobic planktonic growth. Our results have suggested that DHQ
activates PqsR similarly to PQS and HHQ; however, conditions found during CF lung
colonization may limit alkylquinolone production [120, 140]. Further complicating
alkylquinolone syntheses are potentially altered fatty acid pools and lower cellular energy
found in biofilms [156, 157]. Therefore, DHQ may play a role that is different from what
has been traditionally considered for alkylquinolones during chronic colonization of the
CF lung.
Strict anaerobic cultures of P. aeruginosa do not contain PQS and have fewer
transcripts compared to aerobic cultures [158]. To determine how DHQ production might
be affected during anaerobic growth, we quantified quinolones from PAO1 cultures
grown aerobically and anaerobically (Fig 2.5). Increased C4-HSL over 3-oxo-C12-HSL
concentrations in the anaerobic samples has been shown previously that QS molecule
production was maintained without the presence of oxygen [119]. DHQ was the most
abundant quinolone (65µM) produced under aerobic conditions in LB, but was less than
then homoserine lactones (72 and 83µM).
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Figure 2.5 Quantification of extracellular levels of DHQ from aerobic and anaerobic
PAO1 cultures. (A) PAO1 cultures were grown aerobically in LB and anaerobically in
LB+400 µM sodium nitrate until the culture reached OD600 of 2.0. Culture
supernatants were acidified with formic acid and QS molecules were analyzed using
HPLC-MS. The concentrations were determined using calibration curves of QS
standards. (B) PAO1 cultures in SCFM were treated in the same manner and grown
aerobically and anaerobically to determine the concentrations of QS molecules. Data
represented as scatter plots with the mean (central bar). The data was statistically
analyzed using a Student's T-test (* p = 0.05, *** p < 0.0001).
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When comparing the amount of DHQ between the different environments,
anaerobic culture supernatants contained increased concentrations of DHQ compared to
aerobic cultures. PQS was maintained at 10µM between both types of media; however,
PQS was not detected under anaerobic conditions. To our surprise, HHQ was detected in
aerobic and anaerobic cultures, but was below our limit of detection (<100 nM). Blinded
controls verified that the extraction methods did not affect detection of the quinolones or
homoserine lactones. Nutrient between the different types of media used appears to have
an effect on QS molecule production because relative levels of the molecule shift
between the different media regardless of oxygen availability. Comparison of the DHQ
concentrations between LB and CFMM identified that DHQ production was slightly
higher in the media most representing the CF lung environment, but was not statistically
significant (p>0.05). The increase in DHQ and decrease in the alkylquinolones shows that
precursors are possibly shunted over for DHQ production and less for HHQ. Importantly,
DHQ was the most abundant QS molecule under anaerobic conditions in CFMM. This
result indicates DHQ might have specific function within the Pqs system under anaerobic
conditions; however, further research is needed to understand P. aeruginosa
transcriptional regulation in hypoxic conditions and the dynamics of QS molecules within
the mucous.
P. aeruginosa secretes PQS and HHQ through different mechanisms. PqsH,
responsible for PQS synthesis, locates to the bacterial membrane and is thought to
participate in membrane packaging of PQS into the blebs that are released into the
environment. HHQ is not secreted through this mechanism, which was a surprise given
55

the similarity in structure to PQS. An efflux pump, MexEF-OprN, was found to be
responsible for HHQ secretion. The MexEF-OprN efflux pump is a RND-type efflux
pump, which has a role in antibiotic resistance because those pumps are promiscuous
with their target molecules. MexAB-OprM, another RND-type efflux pump, is
responsible for ciprofloxacin resistance [159]. Although the fluoroquinolones have a
similar structure to the quinolones, knocking out the Mex-EF-OprN pump resulted in
increased pyocyanin production because the quinolones accumulate within the cells and
activate the Pqs system (Fig 2.6). Loss of the negative regulator mexS slightly decreased
pyocyanin, which is thought to be a result of increased efflux pump expression. MexT is
a positive regulator of the MexEF-OprN pump; thereby, the loss of mexT also resulted in
increased pyocyanin production. MexS negatively regulates the efflux pump and resulted
in decreased pyocyanin production, presumably through the increased expression of the
efflux pump. We hypothesized that the MexEF-OprN efflux pump would also be
responsible for secretion of DHQ from the cell and found loss of mexE and mexT both
resulted in decreased extracellular DHQ concentrations, while loss of mexS resulted in
increased extracellular DHQ. Together, the data showed a relationship with DHQ
secretion and a functional MexEF-OprN efflux pump.
It is important to note that the MexEF-OprN efflux pump is affected by the Rhl
system, the Pqs system, and antibiotic selection (i.e. fluoroquinolones) [160]. There is
currently no direct connection between the efflux pump and the Rhl system, but mutants
of the pump dramatically affect rhamnolipid and swarming behavior. Antibiotic selection
provides an interesting interaction because most wild-type P. aeruginosa strains possess a
short insert within the positive regulator mexT.
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Figure 2.6 Effect of MexEF-OprN efflux pump on secretion of DHQ.
Wild-type and transposon mutants were grown and assessed for
pyocyanin production and extracellular DHQ. Samples were measured
in duplicate. The average and standard deviation were plotted on the
graph.
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Following growth in the presence of antibiotics, mutants are selected that no longer
contain the insertion and have increased expression of the efflux pump. As a consequence
of the expression, the bacteria resist antibiotic treatment and quinolones secretion is
increased. This new phenotype provides interesting context for P. aeruginosa during an
infection and may have an impact on chronic colonization.
A hallmark of QS is the regulation of community behaviors, which involve the
coordinated action of bacteria together. QS regulation proceeds through a stepwise
process of signaling and transcriptional regulation. The outcome of the signaling cascade
results in the bacteria acting like multicellular organisms. In P. aeruginosa, swarming
and biofilm formation are well established for their QS regulation. Swarming bacteria
move together across a surface. P. aeruginosa swarms coordinate both preparation of the
surface by secreting rhamnolipids and flagellar movement in a uniform direction.
Swarming on an agar surface shows P. aeruginosa move together as tendrils from a
central inoculum. Signaling from P. aeruginosa prevents the tendrils from intersecting,
even to the point of ceasing the tendril from moving in a direction that is too close to
another tendril.
Swarming requires rhamnolipid section, which is regulated by the Rhl system.
Rhamnolipids are composed of mono and di-rhamnose moieties coupled to C10 fatty
acids. The Pqs system participates in regulation of the Rhl system by activating
transcription of the rhl operon. In our study, we found that quinolone production was
essential for swarming (Fig 2.7).
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Figure 2.7 Swarming of wild-type and pqs mutants. Culture were inoculated at a
central point on the agar and incubated overnight. Pictures of the agar plates were
taken using a gel-dock with a positioned camera. Assays were performed in
duplicate. Pictures were taken from the same assay.
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Loss of quinolone production resulted in no movement from the central inoculum
compared to growing tendrils of PAO1. Production of DHQ maintained some movement
out from the central inoculum but no differentiated tendrils. These results demonstrated
DHQ production was able to stimulate some activity from the Rhl system, but
alkylquinolones may have a predominate role in cross-regulation for rhamnolipid
production.
Biofilm formation also requires QS regulation to coordinate the sessile
community phenotype. After initial attachment, a transcriptional signaling cascade
initiates leading to maturation into a biofilm and dispersal of biofilm progenitor cells,
which are all events that go on throughout the lifecycle of biofilm growth. Biofilms use
an exopolymeric matrix that acts as ‘glue’ to hold the community together. The
exopolymeric substance consists of both positively and negatively charged organic
compounds such as polysaccharides, amino acids, DNA, and lipids. P. aeruginosa
provides extracellular DNA for the matrix by lysing its own cells. This is known as
autolysis and is essential for biofilm formation. PQS induces autolysis by acting as a
oxidant and sensitizes the bacteria to ROS in the environment, which subsequently kills
bacterial cells [136]. Using a long-term culture of the P. aeruginosa strains, we examined
how the production of different quinolones affected autolysis (Fig 2.8). PAO1 cultures
lost bacterial density overtime after initial log and stationary phase growth (after 24 h).
This was previously established due to the effects of PQS production. Conversely, strains
∆pqsAB and ∆pqsB did not display as significant of losses in bacterial density and even
displayed some rebounding over time. Because of the connection between autolysis and
biofilm formation, we identified similar trends in biofilm formation among the strains.
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Figure 2.8 Long-term growth and biofilm formation of wild-type and pqs mutants.
Cultures were measured following initial 24 h incubation at OD600 nm. The
average from two assays was plotted per strain. Biofilm formation was assessed in
96-well plates over the indicated incubation times. Biofilm samples were
measured in triplicate with the average and standard deviation listed.
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PAO1 formed the largest biofilms after 72 h, followed by both ∆pqsAB and ∆pqsB.
Together, the trends in both autolysis and biofilm formation demonstrated DHQ was not
involved in autolysis or the signaling involved to initiate those mechanisms.
Metabolic pathways oxidize and reduce diverse organic substrates in order to
recycle or synthesize new precursors. As a consequence, electrons may accumulate and
can be highly toxic if not neutralized. Pyocyanin is a redox molecule and is important for
P. aeruginosa for virulence and electron shuttling [161]. To detoxify the cells and
promote respiration under anaerobic conditions, pyocyanin accepts electrons and gives up
them to other molecules that diffuse away from the cells [162]. The capacity to accept or
give up electrons can be measured using cyclic voltammetry.
Data generated from CV experiments identify whether the molecule of interest is
redox active, and if so, what are the reduction and oxidation peak potentials. To assess
the oxidized and reduced states of the molecule, the potential of the working electrode
cycles in reference to a second electrode. The oxidation and reduction peaks for
pyocyanin were determined to be -84 mV and -294 mV, respectively. Redox properties of
PQS and DHQ were also tested. PQS displayed a small oxidation peak compared to
pyocyanin, but did not have a corresponding reduction peak. PQS was previously found
to have a voltammetric response at 0.768V and 1.182 V using more sensitive apparatus
[163]. DHQ did not show any changes in potential indicating that DHQ neither gained
nor lost electrons under the conditions tested (Data not shown). We had hypothesized that
the large extracellular concentration of DHQ may play a pivotal role protecting the cells
from electrons during both aerobic and anaerobic conditions. In light of the long-term
growth study, production of DHQ correlated with increased survival, but the protective
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mechanism may not be through scavenging ROS. Rather, the mechanism may be from
not producing ROS. Therefore, the connection between DHQ and long-term survival
remains an important question.
DHQ reduced viability of host cells and antagonized cytokine production.
Zhang et al. showed mouse-derived lung epithelial cells treated with DHQ had reduced
viability in a dose-dependent manner [93]. In order to determine if DHQ had a similar
effect on other cell types, we also tested the effect of DHQ on A549 lung epithelial cells
and RAW264.7 alveolar macrophages for respiration and cell death (Fig 2.9). The MTS
assay examines cellular oxidoreductase activity, which can reflect metabolism of the cells
[164]. Sputum samples contained on average 150 µM DHQ from stable and exacerbated
cystic fibrosis patients and was included in the concentrations tested (Clinical data
covered in Chapter 4). RAW264.7 cells displayed increased sensitivity to DMSO;
therefore, we used lower concentration of DHQ for treatment. DHQ reduced the MTS
colorimetric conversion to formazan from both cell types in a dose-dependent manner,
but displayed a greater effect towards RAW264.7 cells. Total respiration was lowered by
25% from A549 cells and 50% for RAW264.7 cells at the highest DHQ concentration
tested. We predict that the lower total cell counts accounted for the lower A549
respiration in the MTS assay. This was supported by experiments with confluent cells
that did display reduced respiration (Data not shown). DHQ supplemented to RAW264.7
cells affected both cell replication and metabolic activity. The high concentrations of
DHQ secreted into the environment may be another mechanism used by P. aeruginosa to
protect itself from the host’s immune system.
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Figure 2.9 Viability of A549 lung epithelial cells and RAW264.7 macrophages
treated with DHQ. (A) Cell viability was assessed using a commercial kit for
respiration. (B) Total and dead cells were quantified from A549 lung
epithelial cells follow treatment with 200 µM DHQ. (C) Total and dead cells
were quantified from RAW264.7 cells treated with 100 µM DHQ. All Assays
were completed in triplicate. The average and standard deviation are shown
through column height and error bars. Student’s T-test was used to compare
samples.
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Alkylquinolones HHQ and PQS were previously found to reduce IL-6 and TNF-α
production following treatment of macrophages with supernatant from wild-type and pqs
mutants. In the same study, the effect of quinolones on cytokine production identified
that HHQ and PQS reduced NF-κB binding function as a transcription factor [165].
It was also determined that PQS reduced IκB degradation, a repressor of NFκB[165]. Due to the similarity in structure, we predicted that DHQ may also lower
cytokine production through the same mechanisms as HHQ and PQS. In order to test the
effect of DHQ on cytokine production, DHQ was incubated with LPS-activated
macrophages (Fig 2.10). IL-6 production was depleted following increased
concentrations of DHQ, while the same treatment reduced TNF-α production more than
50%. Because of the antagonistic effect seen by DHQ on cytokine production, a
significant consequence of DHQ production may be the dramatic alteration of cytokine
signaling from host cells. The high extracellular concentration of DHQ supports this
hypothesis, but further clinical work remains in order to elucidate the role of DHQ during
disease.

65

Figure 2.10 Cytokines measured from LPS-activated macrophages treated with
DHQ. After treatment, extracellular aliquots were removed and tested using
separate ELISA kits for both cytokines. Assays were conducted in duplicate
with at least six replicates per sample. Concentration of cytokines was
determined after generating a standard curve with purified TNF-α and IL-6. Bar
graph shows mean and standard deviation of the samples.

66

2.3 Discussion

Our work provides the first evidence that DHQ is involved in P. aeruginosa
pathogenicity and may have a specialized extracellular role. Those strains only able to
produce DHQ maintained pathogenicity during infection of C. elegans. Specifically, the
DHQ-only strain resulted in increased colonization in the nematodes and maintained
some pyocyanin production compared to the quinolone-null mutant. DHQ was the most
abundant quinolone regardless of oxygen availability and may be secreted via the
MexEF-OprN efflux pump. We determined DHQ could participate in swarming, but may
not have the redox properties to support autolysis and long-term biofilm formation.
Finally, we found an extracellular effect of DHQ against host cells. DHQ reduced cell
metabolism of both epithelial cells and macrophages, while having a strong effect on
reducing cytokine production of macrophages stimulated with LPS.
P. aeruginosa and its host are involved in complicated interactions, which no
infection model can completely resolve. C. elegans is easy to manipulate and has been
previously studied for bacterial and host mechanisms that are important for infection
[166]. However, C. elegans lacks tissue diversity and does not have an adaptive immune
response. These properties limit C. elegans as a model for chronic infections, but C.
elegans is useful as a model of acute bacterial infections. Results from studies using P.
aeruginosa and pqs mutants have shown that a functional Pqs system is important for
infection in C. elegans and other models [167, 168].
We compared mutants only able to produce DHQ to a quinolone-null mutant in
order to determine the function of DHQ apart from the alkylquinolones. However, a
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mutant that produces the alkylquinolones, but not DHQ would have been an important
comparison to establish the functions DHQ play within the quinolone system. We were
unable to identify residues in PqsD from the crystal structure that would block malonylCoA binding, yet maintain interactions with longer fatty acids. For our study, certain
assays required the use of a quinolone-null mutant supplemented back with
alkylquinolones.
Pyocyanin production was maintained in the ΔpqsB mutant compared to the
quinolone-null mutant. Similarly, both PAO1 and ΔpqsB culture supernatant
supplementation increased pyocyanin production when added to a growing ΔpqsAB
culture. Exogenous supplementation of DHQ did not increase pyocyanin production in
the ΔpqsAB mutant. We are currently studying the bioavailability of extracellular DHQ
and whether rhamnolipids are important for solubilizing DHQ to pass through the
membrane. In solution, multiple species of the quinolones may exist through
tautomerization between the carbonyl-groups. DHQ is a planar molecule, but may be
charged in solution, which could affect crossing of the bacterial membrane. Importantly,
no quinolone has been studied for their ability to cross the membrane, but studies have
identified the membrane of having a regulatory role with the QS systems [169]. Not only
are the dynamics with the membrane not understood, but we are still attempting to
understand the influence of the biofilm matrix and QS molecule retention. QS molecules
possessing hydrophobic moieties transiently bind to amyloid fibers that can retain the QS
molecules close to the biofilm [39]. DHQ does not contain a similar hydrophobic group
and may be retained in a different manner within the matrix.
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The MexEF-OprN efflux pump secretes HHQ; therefore, we hypothesized the
pump would also secrete DHQ based on structural similarity. We found extracellular
DHQ decreased and increased based on mutants of the Mex system that either blocked its
function or increased its activity, respectively.
Anaerobic metabolism and regulation of the Pqs system is connected by the
nitrate reduction system [158]. In our work, we showed that regardless of oxygen
availability, DHQ was secreted in high concentration. During anaerobic growth, nitrogen
assimilation systems provide nitrate as an alternative electron acceptor; however,
regulators of nitrogen assimilation systems reduce activity of the Pqs system. We
hypothesize that DHQ may maintain low activity of the pqs operon over time, or, DHQ
may be stored in intracellular pools. Under anaerobic conditions, MexEF-OprN is upregulated [101, 170]. In light of the secretion of DHQ through an efflux pump,
anaerobiosis may be a trigger for a large release of DHQ into the environment. A large
intracellular pool released under anaerobic conditions would explain why transcription of
the Pqs system is reduced; yet we see an increase in DHQ concentration. Toxicity of
DHQ towards host cells provides an extracellular role for DHQ to help P. aeruginosa
maintain the environment under anaerobic conditions (24).
Community behaviors help to protect P. aeruginosa from environmental changes.
We identified a strain that maintained DHQ production displayed some swarming
compared to a quinolone-null mutant, but both strains appeared dramatically reduced
compared to wild-type. This may be due to reduced cross-signaling of DHQ-PqsR with
the Rhl system. Only PQS-PqsR has established function to activate the Rhl system and
stimulate rhamnolipid production. After comparing the effects of DHQ on the community
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behaviors, DHQ may not be primary initiator of multicellular phenotypes, but may
maintain them under certain circumstances.
Redox chemistry plays an important role in metabolism and other exploited
phenotypes from P. aeruginosa. DHQ did not display the same redox properties found
with PQS as observed through autolysis, long-term biofilm formation, and cyclic
voltammetry. Although redox of PQS is important for biofilm formation, autolysis
requires close regulation so that the community is not disturbed by extensive cell
breakdown. The anaerobic environment, which enriches for extracellular DHQ, may not
require autolysis or that autolysis has already occurred for community development.
Our results help to show that different quinolone species may have specialized
and redundant functions depending on the environment. Previous studies indicate that
environmental and internal signals regulate QS and expand the functions of the
molecules. The diversity of quinolones provides another level of complexity to
understanding Pqs system regulation and activity, but may help to determine why P.
aeruginosa is a successful human pathogen.
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Chapter 3: DHQ activates PqsR for transcription of the pqs operon
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3.1 Introduction
QS molecules target transcriptional regulators in order to synchronize community
phenotypes and pathogenicity. In P. aeruginosa, homoserine lactones activate LuxR-type
transcriptional regulators, while the alkylquinolones activate a LysR-type transcriptional
regulator. The QS systems function together in a hierarchal manner, which may play a
regulatory role between the QS systems [131]. The Las system is initiated earliest during
growth and positively regulates both the Rhl and Pqs systems. Following the hierarchy,
the Pqs system and Rhl system differentially regulate each other [87]. Although
transcriptomic studies elucidated the changes in gene regulation following QS, synthesis
of the QS molecules and interactions with target transcriptional regulators still remain an
important area to investigate.
PqsR binds with alkylquinolones and is subsequently activated for DNA binding.
LysR-type transcriptional regulators can function as both positive and negative
regulators, but all share a similar size of about 300 amino acids and domain composition;
a C-terminal ligand binding domain and a N-terminal DNA helix-turn-helix binding
domain. LysR-type transcriptional regulators are often divergently transcribed from their
target operon and require co-activators, which are part of a feedback loop [171]. PqsR is
unique in that the regulator associates in the membrane until early stationary phase
growth and is then released from the membrane into the cytoplasm [171]. Following
release into the cytoplasm, a target ligand activates PqsR. Of the alkylquinolones, PQS is
the most potent activator of PqsR; however, HHQ can also activate the transcriptional
regulator [112]. Importantly, the preference of PqsR for PQS over HHQ includes activity
with other target genes [112]. No other quinolone has been elucidated for their potential
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to activate PqsR even though quinolones share a similar structure. Overall, both QS
molecule production and a functional PqsR are essential for virulence in a model of
infection [82, 172].
Illangova and Williams were the first group to publish a crystal structure of PqsR,
2.5 Å, of both a native and ligand-bound form [173]. This was a significant increase from
the previous analysis at 3.25 Å [174]. From the structures, they elucidated two ligandbinding domains; Domain A and Domain B participate in coordinating alkylquinolone
binding. While Domain A coordinates with the alkyl-moiety, Domain B encloses the
bicyclic ring on either side and coordinate the molecule via two leucines and an
isoleucine. Of the local amino acids, quinolones may form a hydrogen bond with Leu207.
Following activation, PqsR binds to a consensus region –45bp upstream of the
pqsA transcription initiation site to coordinate the loading of RNA polymerase for
transcription of the operon [175]. The -45 region contains the LysR-box, a symmetrical
purine/pyrimidine dyad, which shares similar sequence homology to promoter regions
upstream of lasA and rhlA. PqsR regulates transcription of over 200 genes, many of
which are involved in pathogenicity [171]. Both PQS and HHQ activate PqsR similarly in
vitro, but PQS was found to be more active in activating production of pyocyanin [138].
Our study seeks to understand the interaction of DHQ, the most abundant
quinolone, with PqsR. We hypothesize DHQ activates PqsR similarly to HHQ and PQS
for transcription of the pqs operon. Our results will determine whether DHQ plays a
redundant role to PQS and if DHQ has a specialized function during conditions when
alkylquinolone synthesis is reduced.
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3.2 Results
Several studies and a crystal structure demonstrated PQS to be a ligand for PqsR;
however, further work to determine the function of other quinolones remains an
unanswered question. Quinolones share a similar structure, yet most quinolones remain
undetermined because of the low concentration found in culture. DHQ is a novel
quinolone with no previously determined function, while its concentration is highest
among quinolones produced.
DHQ activated PqsR for transcription of the pqs operon. To determine how
DHQ affects pqs operon transcription, we used quantitative real-time PCR (qRT-PCR) to
monitor the expression of pqsA from PAO1 and pqs mutants grown to early stationary
phase (Fig 3.1) (OD600 = 1.8). This phase of bacterial growth was selected because we
had previously determined pyocyanin production at this bacterial density. Using the
comparative threshold cycle numbers, levels of pqsA transcripts were 47% in the ΔpqsB
mutant when normalized to PAO1. Comparatively, strains ΔpqsAB, ΔpqsR, and ΔpqsBR
expressed pqsA at basal levels. We predicted the low transcriptional activity from the
ΔpqsAB and ΔpqsR strains because it had been established that quinolone production and
PqsR were required for transcription of the pqs operon [87, 138]. Transcription of pqsA
from the ΔpqsBR strain, which produces DHQ but not PqsR, demonstrated that DHQ and
PqsR are both essential for activity from the QS molecule.
Quinolone-activated transcription of the pqs operon further increases production
of quinolones and pyocyanin. The later requires both PqsE and PqsR. Therefore, we
examined if the mutants differentially expressed pqsE. Bacteria transcribe operons to
create a poly-cistronic transcript.
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Figure 3.1 Expression of pqsA and pqsE in PAO1 and pqs mutants. Strains
grown in LB until cell density reached OD600nm of 1.8. House-keeping gene
rpoD was used for normalization. Relative abundance of pqsA and pqsE
transcript level determined using ∆∆Ct method and compared with PAO1,
which was set at 1. Experiments were performed in triplicate with data shown
as mean ± SE. Expression of pqsA and pqsE from the ∆pqsB mutant was
significantly different (p < 0.05) compared to mutants of ∆pqsAB, ∆pqsR, and
∆pqsBR using the Student’s T-test.
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The genes are translated individually because the sequences contain their own ribosomal
binding site, start site, and translational termination site. Although the general trend of
expression mirrored what was found with pqsA, we were surprised to determine a
difference in the expression of pqsA and pqsE from the strains. The ∆pqsB mutant
maintained similar expression to wild-type, while the other mutants displayed reduced
expression, although higher than previously expected. The increased expression of pqsE
may indicate other systems are involved that regulates transcription at the end of the
operon. However, due to the lack of pyocyanin from some of these strains, a threshold of
expression may exist as another level of regulation. There may also be cofactors involved
that are only available with quinolone production.
To further investigate the exogenous and endogenous activity of DHQ on PqsR,
we performed promoter-fusion assays in E. coli and in the P. aeruginosa strains (Fig 3.2).
The promoter-fusion construct contained the upstream regulatory element (-500 bp) of
pqsA fused with the coding region of LacZ [176]. The construct also contained a copy of
the pqsR gene, which was controlled by a tac promoter. DHQ supplemented to E. coli
containing the reporter construct displayed a dose-dependent increase in LacZ activity.
However, activity from 100 µM DHQ was significantly less compared to 1 µM PQS
treatment. We also tested the effect of endogenous quinolone production on LacZ
expression. DHQ from the ΔpqsB mutant was sufficient to activate LacZ activity similar
to wild-type, while the ΔpqsAB strain displayed minimal activity.
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Figure 3.2 Reporter assay of PqsR activity in E. coli and P. aeruginosa. (A) DHQ
supplemented to E. coli carrying the reporter construct pEAL08-2. LacZ activity in
cells treated with DMSO was set as the baseline (1µM PQS – 100 µM DHQ, p =
0.013). (B) Overnight cultures of PAO1 and pqs mutants containing the reporter
plasmid were used to determine the effect of endogenously generated DHQ on PqsR
activation of pqsA promoter (no activity from pqsAB mutant). (C) Cosupplementation of 100 µM DHQ with 30 µM HHQ or 30 µM PQS in E. coli reporter
(HHQ – HHQ/DHQ, no sig. difference; PQS – PQS/DHQ, no sig. difference). (D)
Competition of 100 µM DHQ or 30 µM PQS with 250 µM farnesol in the E. coli
reporter (DMSO/farnesol – DHQ/farnesol, p = 0.0023). Data gathered from at least
duplicates of independent experiments and represented as mean ± SE. Data was
statistically analyzed using the Student’s T-test.
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Due to potential differences in PqsR affinity for DHQ and PQS, we chose to look
at the interactions of DHQ with HHQ and PQS co-supplemented to the E. coli reporter
system. DHQ combined with either HHQ or PQS did not significantly alter LacZ
expression compared to HHQ or PQS alone. No change in activity following cosupplementation may indicate that PqsR has significantly higher affinity for the
alkylquinolones compared to DHQ.
Various fungal species produce farnesol as a quorum-sensing molecule [177].
Farnesol was discovered to be an antagonist of PqsR activity leading to decreased
transcription and pyocyanin production in P. aeruginosa [176]. In the E. coli reporter
system, farnesol reduced LacZ level below the background activity that was established
by vehicle treatment. DHQ supplemented with farnesol rebounded activation of the
reporter indicating DHQ out-competed the inhibitor of PqsR. The increase in activity was
similar to what was found when PQS was supplemented with farnesol.
Taken together, endogenous transcription of pqsA from PAO1 and pqs mutants
and activity from exogenously supplemented DHQ supplemented both show DHQ is able
to activate PqsR for transcription of the operon.
In vitro assays demonstrate DHQ interacts directly with PqsR to bind with
the promoter of pqsA. Few studies have investigated the direct interactions of PQS with
PqsR until a crystal structure was solved [88, 139, 178]. Using this structure, we
performed in silico docking of DHQ with PqsR to determine if DHQ interacted with
similar amino acids compared to PQS (Data not shown). Modeling revealed DHQ
potentially formed hydrogen bond to coordinating amino acids Ile236 and L208 similar to
PQS, while also making novel hydrogen bonds with Ser196 and Glu194. Because DHQ
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does not possess an alkylation, we did not observe any coordination to the second
hydrophobic pocket identified with the alkylquinolones.
To look at direct binding of activated PqsR with the promoter region of pqsA, we
used the electrophoretic mobility shift assay (EMSA) with biotinylated-pqsA (Bio-pqsA)
supplemented to PAO1 and the pqs mutant strains (Fig 3.3). Similar experiments
identified the interaction of PqsR with the phn operon sequences, so we also sought to
confirm the interaction with DHQ as the co-activator [172]. Only PAO1 and ΔpqsB celllysates slowed pqsA migration through the gel, while the ΔpqsAB and ΔpqsR mutants
displayed no interaction with the probe. This result confirmed that factors specific to a
strain that produced PqsR and DHQ were required to interact with pqsA. Addition of
unlabeled pqsA to PAO1 and ΔpqsB cell-lysates increased the free pqsA probe
demonstrating the interaction was specific for pqsA.
Because other systems within P. aeruginosa may affect the activation of PqsR for
DNA binding, we recombinantly expressed PqsR in E. coli Rosetta and monitored the
interaction of the pqsA probe with the cell-lysate. E. coli does not possess a homologous
quinolone system; therefore, the bacteria can be used to document the interaction with the
non-native system. Incubation of PqsR-containing lysate with exogenous PQS or DHQ
initiated binding to pqsA, but not with DMSO alone. Therefore, a quinolone was required
to activate PqsR for binding to the target region of pqsA. The shifts of the probe were
compared to a Rosetta strain containing a His-SUMO tag only, which would show any
non-specific interactions. The activation of PqsR only in the presence of quinolones
indicated a specific interaction was involved in order to initiate QS and transcriptional
regulation.
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Figure 3.3 Electrophoretic mobility shift assay with pqsA. (A) EMSA assays
with Biotinylated-pqsA (Bio-pqsA) probe incubated with cell-lysates of PAO1 and
pqs mutants. (B) The interaction was specific for pqsA promoter as unlabeled-pqsA
competed with Bio-pqsA probe. (C) Both DHQ (200µM) and PQS (30µM)
promoted the interaction between recombinant PqsR with Bio-pqsA. (D) DHQ (0-5
µM) and PQS (0-1 µM) promoted recombinant PqsR binding to Bio-pqsA probe in a
concentration dependent manner. Quantification of free Bio-pqsA was performed
using ImageJ software and non-linear curve fitting was done using GraphPad Prism
software to determine the apparent Kd of PqsR for DHQ and PQS.
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EMSA was previously used to study acyl-homoserine lactones binding with
QscR, an orphan regulator [179]. We were able to use a similar method to semiquantitatively determine affinity of PqsR to DHQ and PQS by measuring free Bio-pqsA
with titrations of the quinolones to the system. Increasing concentrations of DHQ and
PQS resulted in decreased free probe and increased retarded probe. From the curve of
concentrations with density of free probe, the affinity of PqsR for DHQ was determined
to be 150 nM and 33 nM for PQS. The difference in affinity was consistent with trends
found previously with DHQ and PQS supplemented to the E. coli pqsA’-LacZ reporter.
Compared to other published work, they identified in vitro affinity of PqsR for PQS to be
around 1 µM [180]. The Kd for the alkylquinolones from these experiments appears to be
method-dependent. For our purposes, results from the EMSA demonstrate DHQ activates
PqsR for subsequent transcription of the operon.
Saturation transfer difference NMR (STD-NMR) can be used to study proteinligand biding in solution [181]. Saturation from the complex is assessed and the ligand
signals are averaged following the overall effect in the free-state. A 1D 1H NMR
experiment is initially run at the thermal equilibrium for the off-resonance of the sample.
Afterwards, the sample is run for on-resonance, during which some protons are
selectively irradiated for a given saturation time. The off-resonance and on-resonance
signals are subtracted, which leads to a positive difference between the molecules that are
affected. After isolating those peaks that were derived from the ligand, changes in peak
intensity throughout the titrations determine the Kd and identify residues on the ligand
that directly interact with the protein.
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Figure 3.4 STD-NMR of DHQ titrated to PqsR-C87. (A) STD-NMR spectra
of 1 µM SUMO-PqsR-C87 titrated with 10 nm to 100 µM DHQ. A close-up
view of the changing spectra was used to highlight the differences in peak
intensities following increased DHQ concentrations. (B) Peak intensity of
the most prominent peak (close-up view) versus concentration of DHQ was
used to determine Kd of binding. (C) STD-NMR of 100 µM DHQ added to 1
µM SUMO-PqsR-C87 and measured for saturation times in 0.5 sec intervals.
Intervals selected to show saturation from initial incubation to 5 sec. DCOSY assignments of DHQ used to map interacting hydrogens (numbered
in orange).
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We found PqsR saturation transfer to DHQ after signals appeared in the STD
experiments (Fig 3.4). Novel peaks in the PqsR spectra were quantified for intensity and
modeled for single-site kinetic binding. The Kd was semi-quantitatively determined to be
450 nM. Interestingly, the saturation time showed a strong interaction after 3 seconds,
while exhibiting fast-exchange interactions from 0.5 to 2.5 seconds. The fast-exchange
may be explained by hydrophobic interactions within the hydrophobic pocket until DHQ
is coordinated through hydrogen binding. Using the D-COSY assignments (Fig 3.5), we
mapped the 1-D hydrogen spectra to show that the meta-hydrogen of DHQ participated in
hydrogen-binding with PqsR. The ortho- and para-hydroxyl groups were not resolved
because their hypothesized position was too close to the water peak to tell apart.
We also determined the interchange of the keto-enol tautomerization. In solution,
both species exist, which allows for the coordination of the hydrogen through either site.
PQS can also go through a similar keto-enol tautomerization, but it is not known how the
keto and enol form would affect the overall function of the molecule. For DHQ, we
predict the enol form participates in hydrogen binding; however, both in-solution
chemistry and structure of PqsR bound to DHQ will be required to formally determine
the precise interactions.
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3.3 Discussion
In order to elucidate the interaction of DHQ with PqsR, we performed assays to
determine activity of DHQ on PqsR and the effect of DHQ on transcription of the pqs
operon. Our previous work demonstrated that production of DHQ resulted in phenotypes
associated with an active Pqs system. Based on the similar structure shard by DHQ and
the alkylquinolones, we hypothesized DHQ would also activate PqsR for transcription of
the operon. Both RT-PCR and a reporter construct for pqsA transcription showed that the
strain only able to produce DHQ maintained transcription of the pqs operon similar to
wild-type. We also examined the in vitro interaction of DHQ with PqsR using EMSA and
STD-NMR. Both assays elucidated comparative Kd values for PqsR and DHQ.
Importantly, the assays found DHQ could perform the similar function as PQS and bind
within the same pocket on PqsR. Based on the newly identified transcriptional effect of
DHQ for the Pqs system, we have determined that DHQ shares a role with PQS to
activate transcription of the system and identified a structural scaffold to use for future
inhibitor studies with PqsR.
QS controls target genes in order to regulate gene expression at certain bacterial
densities. The mechanism of QS involves a transcriptional regulator, which is normally
not functional until activated by a cofactor. We determined that production of DHQ
resulted in similar transcriptional activity compared to a strain that possessed an intact
Pqs system. However, we were surprised to find differences in the first and last gene
transcribed in the operon. Previously published work identified a second possible
transcription start site for the operon before the coding region of pqsB [182]. However,
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this work was only examined using RNA-seq and RACE. No other group has published
on this site as a second promoter of the system. Another group also found a short
sequence in pqsC that can be mutated that results in a promoter with high activity [183].
Strains that possess that mutation do not require quinolone signaling for activation of
transcription. Based on the requirement for both PqsR and a co-activator, we are
confident our strains function through the traditional signaling system via activated PqsR.
This is supported through our mutants not expressing Pqs-associated phenotypes unless
activated by a quinolone at the previously established density.
To complement the results from RT-PCR of the pqs operon, we performed assays
with a reporter plasmid that carried the upstream region of pqsA fused with the coding
region of LacZ. DHQ supplied to E. coli harboring the plasmid resulted in a dosedependent increase in LacZ activity, albeit not the level of a lower concentration of PQS.
We also found endogenous production of DHQ activated the reporter system and that
there were no other compensatory mechanisms that could activate the reporter without
quinolones. Interestingly, we were able to recapture phenotypes associated with DHQ
supplemented to E. coli, but not to P. aeruginosa. This may be due in part because of
different membrane composition and the efflux pumps located in the membrane of P.
aeruginosa. To our knowledge, no other group has elucidated the QS molecule dynamics
of crossing the bacterial membrane. This is important because we are just beginning to
understand cross-species and interkingdom signaling.
The Pqs system produces a number of different quinolones, but only HHQ and
PQS have established signaling function. Because DHQ is also produced along with
HHQ and PQS, it was important to determine whether DHQ has any competitive or
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synergistic effects with the alkylquinolones on PqsR. DHQ supplemented with HHQ and
PQS did not alter the level of LacZ activity compared to the alkylquinolones alone. Based
on the lower activity of DHQ with PqsR, we predicted that higher concentrations of DHQ
would affect the alkylquinolone binding. These results demonstrated the affinity of PqsR
for the alkylquinolones were sufficiently higher enough to not be affected by the
increased concentration of DHQ.
Yeast secrete farnesol, which inhibits PqsR activity. Yeast such as Candida
albicans can colonize similar infection environments along with P. aeruginosa. Because
of their close colonization, it is not surprising that both strains would try to inhibit each
other [176]. PQS supplemented to a system containing farnesol showed PQS outcompetes
the inhibitor in order to maintain operation of the Pqs system. We also tested whether
DHQ could outcompete Farnesol and found DHQ supplementation increased LacZ
activity despite the presence of the antagonist. The capacity for another organism to
target PqsR in order to reduce its activity highlights the fact that PqsR is a good target.
With this in mind, we are still struggling to understand the dynamics of P. aeruginosa
within a polymicrobial environment. We predict that bacteria are often involved in
complex synergy and chemical warfare over limited nutrients and space. Over time,
systems among the microbes evolved so that they can compete with the other species.
Successful combat would require blocking those systems that are most effective in
controlling the environment, i.e. pyocyanin and the Pqs system. However, because PqsR
function is important for establishing an infection and maintaining the local environment,
P. aeruginosa has developed several redundant mechanisms to ensure its activity.
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Molecular docking is a tool that can be used to generate hypotheses for how a
ligand interacts with a protein. We used docking to determine whether DHQ binds with
PqsR in silico and what could be the potential coordinating amino acids. We compared
the structure of PqsR with an alkylquinolone and found DHQ could also bind within the
same region. The core-quinolone moiety possessed by the molecules binds within an
interior hydrophobic pocket of PqsR. This was not surprising because of the
hydrophobicity of DHQ would most likely direct the molecule to the pocket. In order to
more comprehensively study the interactions of DHQ and PqsR, in vitro methods EMSA
and STD-NMR can be used to probe separate questions. The EMSA assay determined
that DHQ was sufficient for activating PqsR to bind with the pqsA promoter. We also
could measure the Kd by titrating DHQ into the assay and measuring the effect on the
free-probe. Using software to fit the curve, we were able to elucidate the binding affinity
of PqsR for both DHQ and PQS. Again, PqsR displayed higher affinity for PQS
compared to DHQ. Other methods in publications determine affinity of PqsR for the
alkylquinolones, again in a range from nanomolar to micromolar concentrations.
Therefore, affinity found from the different experiments may be involved in an intricate
relationship with the environment used to test the system and the data gathered from the
assay.
STD-NMR can be used to determine the specific moieties involved in binding
between the protein and ligand. DHQ was titrated into solution containing PqsR-C87, a
truncation of PqsR missing the DNA-binding domain. The DNA-binding domain
contains a helix-turn-helix binding motif, which can be insoluble and lead to poor protein
purification. We found a dose-dependent shift in peaks from PqsR-C87, which indicated
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DHQ interacts the protein. In order to determine the exact amino acids that are
responsible for binding, double-labeled proteins can be pulsed using 2D and 3D NMR
techniques. For our purpose, we solved the structure of DHQ and mapped the peaks of
DHQ during the titration. Both keto-enol forms of the carbonyl fall too close to the
central water peak to be identified individually. However, we were able to determine that
the meta-hydrogen in between the two carbonyl-hydroxyl groups did display an
increasing peak with higher concentrations of DHQ. The intensity of the peak was
graphed based on concentration and used to determine the Kd of PqsR for DHQ. The Kd
discovered from STD-NMR was similar to what we found using EMSA. We hypothesize
that the increased Kd in STD-NMR is due to the environment of assay. STD-NMR
requires the use of phosphate-buffered saline, while the EMSA used cell-lysate and
glycerol. The cell-lysate along with glycerol may maintain the protein in solution better
compared to the buffer, and therefore, yield higher affinity because of the increased
stability.
Overall, we have found that PqsR binds to DHQ. Using both in vivo and in vitro
techniques, we demonstrated that DHQ activated PqsR for transcription. It is important to
note that no other group has discerned which species of quinolone may be required to
participate in binding. DHQ should readily tautotomerize in solution and display two
different charged species. Future work in this field should determine the natural state of
DHQ in the environment and how the different tautomeric forms affect activity with
PqsR. Similarly, the availability of the quinolones will be an important question to
answer because charge and mass action kinetics will be involved in the system.
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Chapter 4: DHQ is the most abundant quinolone in CF patient sputum and correlates
to patient health.
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4.1 Introduction

Cystic fibrosis is a genetic disorder that results in increased sweat chloride and
mucous production. Overtime, other pathologies predominate such as chronic lung
infection and increased immune cell infiltration. P. aeruginosa is one of the most
commonly isolated CF pathogens and becomes the dominant organism in the lungs [184].
During chronic colonization, P. aeruginosa infection leads to progressive lung damage
and respiratory failure [185]
In vitro methods for studying host-pathogen interactions with P. aeruginosa in the
lungs are limited. During chronic colonization, P. aeruginosa and the community
together constantly change due to different selective pressures [186]. Due to the constant
changes within the microbial community, it is not known how the resultant phenotypic
changes affect patient health or the best method to assess virulence from the bacteria.
Overall, the goal for treatment involves either eradication or maintenance of P.
aeruginosa, but success with current therapies is limited.
Bacterial QS controls several community behaviors, which are essential for
causing an infection. P. aeruginosa utilizes three QS systems to control virulence factor
production and community lifestyles such as biofilm formation and swarming. Virulence
factors have been extensively studied in vitro, but their direct involvement in lung
pathology is not well understood. Biofilm and macrocolony formation, which are
established antibiotic resistance mechanisms, have been identified from clinical samples
of CF patients chronically infected with P. aeruginosa [187]. Swarming is less
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understood, but has been hypothesized as a method for P. aeruginosa to further colonize
areas in the lung.
Understanding the survival and fitness mechanisms from P. aeruginosa between
different environments has not been well established. Within a planktonic culture, QS
molecules function through a defined pathway, but these QS systems are altered during
an infection. HSLs regulate community behaviors from the Las and Rhl systems, while
quinolones alter behaviors from the Pqs system. Acidic conditions and certain enzymes
break down HSLs [188]. Host cells may also hydrolyze the lactone ring of HSLs, which
acts as a host defense mechanism [189]. Quinolones are more stable and have few known
enzymes that can affect the ring structure, none of which are produced from a human host
[190]. Based on the stability of the quinolone, those molecules may accumulate over time
during chronic colonization. Of the QS molecules, C12-HSL and C4-HSL have been
quantified from patient samples in order to show P. aeruginosa forms biofilms within the
lungs [191]. Of the quinolones produced, only PQS has been isolated from patient
samples [117]. Phenazines, which are regulated by the PQS systems, have also been
assessed for their impact on P. aeruginosa infection and correlation to patient lung
function [192]. Because the QS systems are inter-regulated, the consortia of molecules
may yield a biomarker of P. aeruginosa community phenotype and virulence factor
production.
For our investigation, we examined P. aeruginosa QS molecules from patients
who maintained their lung function compared to those who experienced an exacerbation,
which was diagnosed as a sudden decrease in lung function and increase in symptoms.
Patients were enrolled in the study for up to three years and their clinical data was
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recorded with the QS molecules from their sputum. Clinical data included: patient sex,
age at the time of sample, genotype, treatment therapies, and microbiology cultures. In
total, 45 patients were recruited into our study and were monitored for both stable and
exacerbation periods. During their clinic visits, patient FEV1 was also recorded at the
time of the sample. Concentrations of the QS molecules were used with statistical
comparisons in order to determine the relationship of QS molecules with patient health
status. We predominantly focused on the most abundant quinolone, DHQ, but also
investigated QS molecules PQS, C4-HSL, and C12-HSL. During the study, we attempted
to correlate QS molecules with maintenance of lung volume, initial exacerbation event,
and treatment for an exacerbation.
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4.2 Results

Inclusion of patients, sputum sample collection, and review of patient medical records
were approved by the Medical University of South Carolina Institutional Review Board.
Adult CF patients were sampled during stable periods of lung function and exacerbations
over three years. Patients were selected using the following criteria: over 18 years old,
had a positive culture-history of P. aeruginosa, non-smoker, did not culture Burkholderia
species, readily produced sputum, and received consistent treatment at the Medical
University of South Carolina Adult CF Center. Those patients included in the study were
consented and were periodically consulted to discuss their view on their symptoms and
pathology. Patients who maintained their lung function gave samples during clinic visits,
and those who underwent an exacerbation gave samples during the hospitalization until
they could no longer produce sputum. The patients enrolled in the study were assessed
not only for QS molecules in their sputum, but also for their sex, genotype, age at sample,
antibiotic therapy, and microbiology cultures (Table 4.1). This study included 45 patients,
23 female and 22 male, who gave over 80 samples during stable periods of disease and
over 50 samples during exacerbations.
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Patients (n1 = 45)
Sex

Samples Received (n2=80)
23 female, 22 male

CFTR genotype, n2 (%)a
ΔF508/ΔF508
ΔF508/other
Other/other

34 (75.5)
8 (17.8)
3 (6.7)

Age at time of sample, yr (+/- SD)b

30.88 (12.15)

Therapy at time of sample, n2
(%)c
single antibiotic
two antibiotics
three antibiotics
Tobramycin (Tobi)
Aztreonam (Cayston)

16 (20)
28 (35)
25 (31)
46 (58)
20 (25)

Microbiology (%)d
multiple Pa strains
Co-culture S. aureus and Pa
Co-culture Pa and fungi

31 (39)
29 (36)
29 (36)

Table 4.1 Demographic and sample information for subjects enrolled in study.
Patients were enrolled for three years and were sampled at both clinical visits
and hospitalizations (or when available). aPercent of total patients (45) for
comparison of CFTR mutation. bAge at time of sample is listed as mean and
(standard deviation). cPer sample percent of antibiotic treatment at the time the
sample was given. dPer sample percent of microorganisms found within the
culture sputum given to the MUSC Microbiology Lab.
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DHQ was the most abundant quinolone quantified from stable CF patient
sputum colonized with P. aeruginosa. Stable patient samples contained several QS
molecules from the three central QS systems in P. aeruginosa (Fig 4.1). Although there
are several methods to detect QS molecules in a sample, mass spectrometry provides a
definitive method for quantification [193]. Previously published work demonstrated that
conditions in the CF lung foster the increased production of C4-HSL and decreased
production of C12-HSL [191]. Our in vitro work similarly found that increased C4-HSL
over C12-HSL was indicative of growth under anaerobic conditions. Results from the
stable CF patient samples were consistent with this trend that P. aeruginosa colonized
anaerobic areas within the lungs. PQS was quantified from the samples as well, but was
significantly lower in concentration compared to DHQ. HHQ was detected in the
samples, but was under the limit of detection, <100nM. Therefore, the rest of the data
focused on C4-HSL, C12-HSL, PQS, and DHQ.
QS molecules between stable patient sputum displayed wide ranges in
concentration (Table 4.2). DHQ was found to have a median concentration of 123 µM
with an interquartile range of 25 to 464 µM. C4-HSL was another abundant QS molecule
quantified in the sputum with a median concentration of 162 µM and an interquartile
range of 41 to 452 µM. Both PQS and C12-HSL were significantly less compared to the
other quinolone and HSL species, respectively.
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Figure 4.1 Distribution of QS molecules from stable CF patients. Samples
quantified from clinic visits and graphed using a scatter plot. Samples (n=33)
are listed with mean and standard deviation. HHQ is not shown because the QS
molecule was below the limit of detection.
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QS Molecules (µM)

DHQ

PQS

C4-HSL

C12-HSL

Minimum

0

0.229

0.6

0.829

25% Percentile

25.3

0.7

41

10.38

Median

123.2

0.8

162.6

21.65

75% Percentile

464.3

0.9

452.1

57.5

Maximum

3192

2.16

1732

507.1

Mean

560.8

0.917

299.4

54.02

Std. Deviation

910.5

0.3458

353.5

89.6

Std. Error

158.5

0.0475

55.2

12.19

Table 4.2 Descriptive statistics for QS molecules in stable patient sputum
samples (n=33).
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DHQ positively correlated with stable patient FEV1. Patient FEV1 is a measure
of patient lung expiratory volume. Measured volumes estimate lung function and
provides an ongoing test to monitor progression of the disease [194]. Although there is a
correlation of increased mortality of CF patients colonized with P. aeruginosa, there is
currently no published report that directly measures the effect of P. aeruginosa on lung
tissue. Because P. aeruginosa caused dramatic changes in cultured cells and secreted a
vast arsenal of virulence factors, we predicted P. aeruginosa destroyed lung tissue either
through direct or indirect mechanisms.
P. aeruginosa produces several QS molecules that directly antagonize host cells. Both
quinolones and HSLs alter host cell viability and cytokine response to LPS-activated
macrophages [195, 196]. We determined DHQ positively correlated with FEV1,
indicating higher concentrations DHQ was associated with higher lung function (Fig 4.2).
No other QS molecule statistically correlated with a change in FEV1. However, C4-HSL
was the next closest trend (p = 0.12), but demonstrated a negative correlation with FEV1.
Our previous in vitro data found that DHQ inhibited epithelial cell replication, while
reducing the viability of macrophages. Another effect on the immune system was
identified when DHQ dramatically reduced IL-6 and TNF-α production from LPSstimulated macrophages. Alveolar macrophages are antigen-presenting cells in the lungs
that react to foreign bacteria. The cytokines produced from the activated macrophages
and other immune cells can induce a large influx of other host immune cells, which
causes collateral damage to the lung tissue in the process. Inhibiting immune cell
signaling would reduce the damage brought on by the immune system following P.
aeruginosa infection [197].
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Figure 4.2 Correlation of QS molecules with patient FEV1. None of the QS
molecules displayed a normal distribution; therefore, correlation of QS
molecules with FEV1 analyzed using Pearsons’s Correlation Coefficient (PCC).
For all samples: n = 33. The PCC of DHQ = 0.36 (p = 0.04), PQS = 0.03 (p = 0.5),
HHQ = -0.21 (p = 0.12), C12-HSL = -0.13 (p = 0.17).
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Genotype and microbiology cultures of patients display changes in DHQ in
stable patient sputum. Although the largest group of patients was homozygous for
∆F508, we found that patients with other mutations displayed differences in the
abundance of DHQ in sputum (Fig 4.3). Other groups have investigated the trend of
patients based on their genotype and overall mortality; however, we are the first to show
trends involved with P. aeruginosa QS molecules [198]. We also investigated the
concentration of DHQ from patients who cultured P. aeruginosa and other
microorganisms. In co-culture, P. aeruginosa alters QS molecule production and
subsequent phenotypes in response to other organisms [151]. We found patients who cocultured Staphylococcus aureus or fungal species displayed increased DHQ in their
sputum. This finding was consistent with other published work that demonstrated that the
Pqs system was upregulated in response to other organisms [151].
We also examined the change in DHQ concentration based on the number of P.
aeruginosa colony morphologies cultured from sputum. The diversity of colony
morphologies is generated, in part, from the Pqs system [199]. We found that the
increasing diversity of colonies was associated with larger concentrations of DHQ. In
light of the correlation of different P. aeruginosa features and FEV1, further work is
necessary to understand the mechanism involved in vivo for the generation of diverse
colonies either through the selection by antibiotics or the functions of the Pqs system.
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Figure 4.3 Correlation of DHQ with genotype, microbiology cultures, and colony
variants. Data displayed as scatter plot. Correlation of DHQ with number of
colony morphologies was measured using Student’s T-test (* p = 0.024). Other
data to be displayed as general trends among the samples.
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Figure 4.4 Correlation of Age, FEV1, and DHQ concentration. Patient FEV1 at the
time of sampling displayed a normal distribution. For comparing FEV1 and age and
also DHQ concentration and age, a Pearson’s Correlation Coefficient (PCC) was
used to determine the statistical relationship. No significant value was determined
between either data set.
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Quinolones are made up of two fused benzene rings with a single nitrogensubstitution. The nature of the ring structure provides a stable structure that could
accumulate over time in an environment. Conversely, HSLs are broken down quickly
over time, especially in acidic environments. We predicted that quinolones accumulate
over time after patients are colonized with P. aeruginosa. First, we investigated if there
was a significant trend in FEV1 compared to age of stable patients (Fig 4.4). No
significant trend existed between FEV1 and age; therefore, we could interpret whether
age and DHQ concentration could be dependent regardless of FEV1. When we compared
the age of patients with their respective DHQ concentration, again we found no
significant trend. We initially hypothesized DHQ would increase overtime due to
accumulation in sputum and in the lungs, but this did not take into account dynamics of
QS molecules during acute and chronic periods of disease. The concentration of
quinolones overall may change based on coughing out sputum and intense lung-clearing
techniques. Although the concentration of QS molecule may fluctuate overtime, we still
may be able to determine accumulation of QS molecules after following patients over
time from their initial positive culture.
Concentration of DHQ does not predict an exacerbation event or change
significantly during and exacerbation. Due to the use of QS systems to regulate
bacterial pathogenicity, we predicted that increased QS molecule production would
coincide with decreased lung function. During this time, we would also expect increased
P. aeruginosa colonization and pathogenicity. Currently, there is no known connection
between P. aeruginosa colonization and exacerbations.
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Figure 4.5 Before-and-after trends of QS molecules with exacerbations.
11 patients undergoing an exacerbation were included in this study
because they had given sputum samples within 7 days of their
exacerbation. Exacerbation samples were from samples given on day 1 of
their hospitalization.
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QS molecules and the relationship to pathogenicity may lead to potential biomarkers
from P. aeruginosa that are related to disease severity.
Quinolones and HSLs were compared between stable periods of disease and the
first day of a diagnosed exacerbation, which was identified as a sudden drop in FEV1 and
general health (Fig 4.5). None of the QS molecules demonstrated consistent trends
between stable and exacerbation events. Both of the quinolones monitored showed
intermixed increasing and decreasing concentrations. Of the HSLs, C12-HSL
demonstrated a mix of trends between the patient health statuses, while C4-HSL
displayed an increasing trend during exacerbations in > 70% of the patients monitored (n
= 11). A much larger sample size is required to elucidate whether this trend is statistically
significant. Importantly, this data provides initial evidence that the Rhl system is
upregulated during an infection. Rhamnolipids are critical for both mobility of P.
aeruginosa on a semi-solid surface and are important for reducing ROS caused by
antibiotic treatment [119].
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Figure 4.6 Change in QS molecule concentration from first day of inpatient
treatment to day 7 of treatment (n=11). Samples displayed as a scatter plot with
mean and SEM listed.
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During an exacerbation, patients are aggressively treated with antibiotics and
respiratory therapy. However, P. aeruginosa survival despite therapy or how antibiotic
treatment affects P. aeruginosa phenotypes in vivo is not known. We monitored QS
molecules from patients undergoing first seven days of an exacerbation (Fig 4.6).
Interestingly, the concentration of DHQ and PQS did not significantly change overtime.
We anticipated a decreasing trend in concentration because the antibiotic therapy should
reduce P. aeruginosa density and/or increase lung clearance, which would affect the
concentration of QS molecules in the lungs. We did determine changes to both of the
HSLs throughout an exacerbation. The changes demonstrated a mix of increasing and
decreasing concentrations. Overall, the trends identified between the QS molecules
indicated P. aeruginosa density was not affected despite therapy, while the HSL
signaling systems were altered during an exacerbation or in the presence of treatment.
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4.3 Discussion

Studying QS from P. aeruginosa in CF patient samples will help to show the
phenotypes of the bacterium during an infection. Because QS regulates community
behavior and pathogenicity in a density-dependent manner, we wanted to determine the
dynamics of QS molecule concentrations in order to determine the phenotype of P.
aeruginosa during disease. We focused on adult patients because the majority of this
patient population harbored P. aeruginosa for years. However, we were unable to know
exactly how long the adult CF patients were colonized, which may have affect
concentrations of the QS molecules in the samples or the relationship to the other
pathologies. Therefore, our work concentrated on QS molecule and their relationship to
current patient characteristics and exacerbation events.
We determined DHQ had a wide distribution of concentrations from patients who
maintained their lung function. DHQ accumulated up to milimolar concentrations in
sputum, which was significantly higher than found in planktonic cultures. It was also
interesting to find the concentration of PQS was more consistent between samples, but at
significantly lower concentrations. We predict the low concentration of PQS was related
to lowered production from P. aeruginosa when grown under microaerophilic to
anaerobic conditions. P. aeruginosa is often studied under aerobic conditions; however,
this bacterium is able to utilize nitrate as a terminal electron acceptor, which is readily
available in the lungs [200]. Growth within these different environments will alter
bacterial phenotypes. In comparison among the different quinolones produced, DHQ was
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secreted in high concentrations both in culture and within the lungs regardless of oxygen
and may play an important extracellular role during an infection.
Our previous work tested the effect of DHQ exogenously supplied to LPSactivated macrophages and subsequent cytokine production. Other published reports
indicated that alkylquinolones reduced cytokine production, but those bacterial small
molecules were not readily available in CF patient sputum. We confirmed DHQ also
reduced cytokine production from LPS-stimulated macrophages and were able to
associate our findings with patient FEV1. Although we did not directly test cytokines
from patient samples, the high concentrations found in sputum support the extracellular
function of DHQ to reduce host immune cell signaling [201]. Infiltrating immune cells
cause collateral damage through normal immune processes that occur when the cells are
fighting an infection [202]. Mice that displayed reduced immune activity did not contain
as catastrophic lung damage compared to wild-type mice infected with P. aeruginosa
[203]. Therefore, our findings are similar with P. aeruginosa colonization controlling the
local immune system by reducing cytokine signaling and preserving the lung
environment. Overall, patients whose P. aeruginosa strains secrete large amounts of
DHQ may initially display higher lung function because the anti-inflammatory effect, but
it is still not known how chronic exposure to DHQ may affect lung pathology.
Different CFTR mutations display different deleterious effects on patient lung
function due to the activity, or lack thereof, from the CFTR [204]. The mutation most
often found within our patients was ∆F508, but we also included patients that did not
possess the F508 mutation. We found patients with different CF mutations displayed
differences in DHQ concentration. However, we did not compare any other patient
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conditions. Larger enrollment numbers may further elucidate a role for DHQ and the
properties of P. aeruginosa infection in the different patients. We also identified DHQ
concentrations change based on other organisms that were co-cultured with P.
aeruginosa. In the presence of Staphylococcus aureus, P. aeruginosa increased
expression of the Pqs system in order to produce a potent alkylquinolone-N-oxide [99].
We found sputum samples from patients that cultured both P. aeruginosa and S. aureus
demonstrated increased concentration of DHQ compared to mono-cultures of P.
aeruginosa. DHQ was also increased when P. aeruginosa was cultured with fungi. Both
P. aeruginosa and yeast have been studied for their interactions; however, it is not clear if
P. aeruginosa directly associates with the yeast or reacts to its metabolites in the
environment [205]. This is an important question for the microbiology of CF patients and
will help to understand another variable to the environment of P. aeruginosa during
chronic colonization. In addition, discovery of two-component regulators and other
sensor systems will be critical for also integrating how P. aeruginosa facilitates its
interaction with the environment.
CF patients undergoing an exacerbation require extensive inpatient care. Based on
the paradigm of CF pathologies, increasing colonization of bacteria in the lungs may play
a primary role in initiating an exacerbation. Quorum sensing coordinates bacterial
community development and virulence factor production; therefore, an increase in QS
molecule concentration may be found before increased bacterial colonization or alteration
of the lung environment. We studied QS molecules from the three established systems in
order to identify how measuring QS molecules can be used as a biomarker for an
exacerbation event. We found that the quinolones did not demonstrate a consistent trend
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between stable and exacerbation periods, while the HSLs showed more uniforms trends.
We initially hypothesized quinolones would show a sharp increase because of their
relationship to growth under anaerobic conditions and virulence factor production.
However, C4-HSL increased more often during the first day of an exacerbation. C4-HSL
is responsible for the regulation of rhamnolipids, which play several roles for P.
aeruginosa. Rhamnolipids are essential for swarming and may play a role in increasing
P. aeruginosa colonization. Furthermore, we identified C4-HSL as a molecule that also
fluctuated during an exacerbation. Limited studies have attempted to understand the
interactions of the colonizing bacteria and the intense treatment received [206]. Previous
work has already elucidated bacteria can react to small amounts of antibiotic in the
environment by increasing biofilm formation [207]. It is reasonable to predict that IV
antibiotic therapy and increased respiratory clearance will dramatically alter QS molecule
synthesis from the bacteria, but these predictions remain to be concluded.
Bacteria within the lungs undergo genetic variation throughout chronic
colonization. Antibiotic treatment, anaerobic metabolism, and host ROS are all drivers of
genomic diversification [208]. The variation in the genome is a result from synonymous
and non-synonymous mutations within genes creating diverse phenotypes within the
environment that compete for dominance [209]. Mutations are generated through a
variety of mechanisms, but most mutations may arise from loss of optimal DNA repair
capability. Therefore, not only is it important to understand how the genome is altered
throughout an infection, but also how global metabolism changes in response to the
mutations and downstream effects on lung pathology. Ultimately, these changes are
guided via selective pressures, which may be both disease and patient specific.
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Based on the limited knowledge of bacterial reactions to antibiotic therapy and
host factors, our data provides some of the initial evidences into understanding how the
bacteria react to frequent changes in the environment. We provide a similar finding that
increasing antibiotics caused alterations to the QS molecules secreted in the environment.
Specifically, the HSLs displayed the most change, while the quinolones were relatively
unaffected. HSL can signal for biofilm formation, but the link between HSL signaling
and biofilm formation in vivo remains limited. The relatively small change in quinolones
was interesting because patients are receiving aggressive therapy with the goal of
reducing the bacterial concentration. If the bacterial community is reduced, we would
expect a consequent reduction in QS molecules. This result would be the same for QS
molecules that have accumulated in sputum. However, the QS molecules remained
relatively unchanged; thereby, molecules that were removed by physical processes were
either replaced or maintained in other pockets within the lungs despite treatment. Because
the homoserine lactones are changing, we expect that those systems are upregulated in
the presence of treatment. Further work is required to determine how long-term cultures
are affected by treatment and how QS may be involved in the persistence of P.
aeruginosa in the CF lungs.
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Chapter 5: Conclusion and future outlook
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DHQ and P. aeruginosa pathogenicity

P. aeruginosa produces several different quinolones, but few have designated
function within the Pqs system. We determined DHQ maintains a redundant ability to
activate PqsR, but also has specialized function for reducing inflammatory signaling. Our
initial results to identify the link between DHQ and pathogenicity utilized the C. elegans
colonization assay and found a strain that only produced DHQ displayed increased tissue
penetration, which may represent a role during P. aeruginosa colonization. The strain
only able to produce DHQ also maintained production of pyocyanin providing another
link to its role in pathogenicity. Apart from the other quinolones, DHQ abundance was
not affected by anaerobic conditions, which is a component of the environment P.
aeruginosa frequently colonizes. Although our work did not identify any redox properties
of DHQ, we did identify a potential role in community behaviors that are essential for
initiating an infection. Importantly, our work also united the function of DHQ within CF
patients who were chronically colonized because of reduced cytokine production and cell
viability. Overall, initial evidence of DHQ and its role within the Pqs system was
confirmed and demonstrated that the novel quinolone performs key roles during active
colonization of a host.
P. aeruginosa stains only able to produce DHQ killed C. elegans significantly
faster compared to a quinolone-null mutant. We were fortunate to have such polarizing
results between the wild-type and the quinolone-null mutant in order to document the
range of virulence. Although the DHQ-producing mutants did not completely display the
total pathogenicity of the wild-type, the results clearly indicated DHQ was involved in
115

one or more virulence mechanisms that were perpetuated by the Pqs system, which may
be required in order to activate optimal virulence. Because both DHQ-only mutants had
similar trends in C. elegans death, we were confident that DHQ played the same role
regardless of pqs gene deletion. The C. elegans infection only displays trends in total
virulence, which is affected by both bacterial colonization and secreted virulence factors.
In order to discern how DHQ production facilitated colonization in C. elegans, we
monitored the real-time colonization of P. aeruginosa strains in the nematode.
C. elegans consumes bacteria as its food-source during its maintenance on agar
plates. Therefore, we were able to incubate C. elegans with the GFP-expressing bacteria
and assess nematodes overtime. Throughout the experiment, we found increasing
bacterial density in the central gut-track. At 144 h, we saw a difference between the wildtype and ∆pqsB compared to the ∆pqsAB mutant. Those strains that produced DHQ
displayed increased dissemination throughout the gut-track, while the quinolone-null
mutant only had minimal fluorescence. This result indicated that the integrity of the
surrounding tissue was compromised as a result of the quinolone or quinolone-mediated
action. There are several mechanisms that can cause this tissue break-down; DHQ
participated in this effect and can cause effects against host cells. This result may help to
explain why CF patients have decreased lung function after reoccurring exacerbations.
Mammalian cells respond to foreign bacteria through complex signaling and
direct cytopathic mechanisms. Numerous studies focusing on CF have attempted to find a
model for chronic infections, but most have not succeeded due to key differences in
biology [210]. Of the models tested, the Porcine model has had the most success and may
hold promise for elucidating key interactions found only during chronic colonization
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[211]. C. elegans does not possess the same immune cell repertoire; thereby, nematodes
respond to pathogenic bacteria via epithelial cell defensins and other basic regulatory
signaling cascades (i.e. PAMPs and host damage) [212]. P. aeruginosa traditionally
activates PAMP TLR4, but some P. aeruginosa strains have been found with altered Olinked oligoglycosides that may not activate the receptor as strongly [213]. C. elegans
may primarily respond to P. aeruginosa infection following cell damage caused by the
bacterium. This aspect of infection response is also found with P. aeruginosa infections
in humans, which demonstrates another parallel for C. elegans as a model. Although C.
elegans captures some key cellular attributes in responding to P. aeruginosa infection,
the model cannot be used to study chronic infections.
Regardless of oxygen concentration, high concentrations of DHQ secreted into
the environment demonstrated a unique feature among the quinolones. Anaerobic
conditions limited all other quinolones, but DHQ was maintained around the same
concentration compared to aerobic growth. These results provide the first evidence that
Pqs molecules not only function during aerobic conditions, but also during anaerobic
conditions. The ability to use quinolones under both conditions helps to show the Pqs
system plays a role in fitness regardless of environment.
Due to alkylquinolones HHQ and PQS requiring an active mechanism to leave the
cell, we also hypothesized DHQ required a secretion system. The initial candidate for
DHQ secretion was the MexEF-OprN efflux pump because the pump was identified to
secrete HHQ. The RND-type efflux pumps are known to be promiscuous and may also
secrete DHQ because of the structural similarity [214]. Results from mutants of the Mex
system showed that increased expression of the pump displayed higher extracellular
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concentrations of DHQ, while loss of pump machinery resulted in lower concentrations.
There is no direct regulatory link between the Pqs system and the Mex system; however,
environmental systems may affect both concurrently. During anaerobic growth,
expression of the MexEF-OprN pump is increased, while antibiotic treatment also
resulted in increased expression [215]. These two environmental changes may both be
responsible for the increased efflux pump expression that has been isolated from strains
in CF patient samples. Our preliminary work found that intracellular concentrations of
DHQ are dramatically affected by anaerobic growth (data not shown). During aerobic
growth, DHQ intracellular pools remain high, while anaerobic growth resulted in
depleted intracellular pools. These results mirror those found with Mex efflux pump
expression. Importantly, this provides an explanation for the anticipated reduced
expression of the pqs operon during anaerobic growth, yet high extracellular
concentration of DHQ. Future work may focus on quantifying transcription of both
systems in order to confirm this conclusion.
The high extracellular concentrations indicated DHQ might have a specialized
role for controlling the environment during colonization. QS molecules from P.
aeruginosa displayed different effects toward host cells, but most demonstrated either
altered cytokine signaling or reduced viability. We determined DHQ reduced the viability
of alveolar macrophages and also limited the reproduction of epithelial cells. Both effects
are advantageous during an infection. Macrophages both consume bacteria as
professional antigen presenters and secrete signals to increase the localized inflammatory
response. Limiting epithelial cell reproduction would reduce the loss of limiting nutrients
to host cells; thereby, allowing for better access for the bacteria. In order to further study
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the effect of DHQ on damaged epithelial cells, scratch tests may be run in the presence of
DHQ to determine how DHQ affects both cell migration and multiplication following
injury. Inability to heal lung tissue following damage would perpetuate the disease and
provide an explanation for the downward trend in lung function after consistent
exacerbations. The effect of DHQ on the immune system demonstrated a direct role for
DHQ with P. aeruginosa colonizing a host. Reducing the local inflammatory signaling
cascade prevents other immune cells from moving in towards the bacteria in an attempt to
kill the pathogens. Although a biofilm or other secreted products such as rhamnolipids
can prevent phagocytosis, a secreted product that was able to reduce inflammation from a
relative distance would be advantageous and help P. aeruginosa control the environment.
The dynamics of DHQ in the environment is still not clear. We hypothesize DHQ
is stable and resists deleterious conditions found with homoserine lactones. Therefore,
DHQ may accumulate overtime unless transported by physical forces. The dynamics of
DHQ is easier to understand within a planktonic culture because the molecule would
exist within the aqueous environment. However, P. aeruginosa can also live as a biofilm;
thereby, the QS molecules interact directly with constituents of the biofilm following
secretion. Biofilms are constructed using polymeric substances that possess different
chemical moieties, which can be hydrophobic, hydrophilic, positively charged, and
negatively charged. These interactions are further compounded in the lungs of a CF
patient because biofilms form in mucus. In solution, DHQ tautomerizes leaving both the
keto and enol form. Based on mass-action kinetics, sequestered DHQ within the biofilm
may become predominantly charged as the keto form switches to the stabilized enol form.
However, this arrangement may have altered properties from what is anticipated for a
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function. These properties include altered signaling, retention in a biofilm, or effect
against host cells. Alkylquinolones possess a hydrophobic moiety that allows it to interact
with the lipid components within the biofilm. DHQ does not have this moiety and may
display different movement within the matrix. No work is available to determine how
DHQ may or may not accumulate within the biofilm compared to the alkylquinolones.
The biofilm matrix alone is a dynamic environment that is actively altered by P.
aeruginosa [216]. Altering the polysaccharides secreted may be one such system
elucidated in P. aeruginosa for modifying the biofilm matrix [217]. As the chemical
dynamics of the biofilm changes, the molecules that are associated in the matrix will also
change. The dynamics of DHQ in a biofilm and the subsequent changes in the biofilm
demonstrate a niche adaptation mechanism that may be important to resist changes in the
environment and the dissemination of the infection.
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DHQ activates PqsR for transcription of the pqs operon

Quinolones not only enact extracellular functions, but also activate signaling
processes via PqsR. We performed several experiments to test whether DHQ is capable
of activating PqsR. However, PqsR activated by alkylquinolones displayed increased
activity, which indicated DHQ may only perform the signaling role in a redundant
manner. With this in mind, we still do not understand the effect or potential for P.
aeruginosa to possess multiple quinolones that appear to initiate similar functions.
Initial assessment of pqs operon activity from the mutants identified that the
production of DHQ increased transcription compared to a quinolone-null mutant. Late
log/early stationary phase growth was significant because time-course experiments
showed initial pyocyanin production at that period. Results from qRT-PCR of strains
grown to late log/early stationary phase found DHQ and PqsR were both required for
transcription. The difference in activity from pqsA and pqsE demonstrated that other
mechanisms may be involved in maintaining transcription of the end of the operon. We
hypothesize that production of pyocyanin may be more beneficial for the cell compared
to quinolone production because of the bacteria’s preference for maintaining pqsE
transcription despite quinolone production.
Data from the real-time experiments were confirmed using a reporter containing a
fusion of the pqsA promoter region and the lacZ gene. We determined that both
exogenous supplementation and endogenous production of DHQ increased activity of the
reporter compared to a vehicle control and quinolone-null control, respectively.
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Importantly, DHQ supplemented to an E. coli strain containing the reporter demonstrated
a dose-dependent increase in activity. This result indicated that DHQ directly influenced
activity. However, supplementation experiments to P. aeruginosa strains did not display
a significant increase (data not shown). The ability to pass through the membrane may
account for why DHQ did not affect co-supplementation with HHQ and PQS, which
possess alkyl-moieties that may become associated with the membrane. We hypothesize
that the charge of DHQ in solution prevents the molecules from crossing the P.
aeruginosa membrane or those molecules that enter are quickly secreted.
In order to cross the membrane, DHQ may require association with another
molecule to increase its hydrophobicity and decrease its charge. Rhamnolipids could
increase the solubility of DHQ and help bring the molecule back into the cell. PqsR
positively regulates the rhl operon for subsequent rhamnolipid production [154].
Together, rhamnolipids may play a role with quinolones to help facilitate their transport.
DHQ supplemented to PqsR in vitro activated the transcriptional regulator to bind
to the promoter region of pqsA. PqsR alone did not bind to the DNA indicating ligand
binding was essential for activity. Again, a dose-response in binding demonstrated DHQ
was another ligand of PqsR and supported the in vivo results from the reporter and realtime experiments. The EMSAs were performed using cell-lysate, which supported the
activity of recombinant PqsR. We performed EMSA in both E. coli producing
recombinant PqsR and in the P. aeruginosa pqs mutants. Both sets of assays concluded
DHQ was sufficient for activity. PqsR contains an insoluble DNA-binding domain and
would precipitate from purification buffer quickly under ambient temperatures. Use of
cell-lysate provided a vehicle to maintain PqsR in solution and may also facilitate the
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interaction of the transcriptional regulator with DNA because of the more
physiologically-relevant environment. Future work may investigate the binding of DHQactivated PqsR to other regions on the pqs operon. Previously published work has
identified potential alternative binding sites for PqsR, but those sites remain to be
substantiated using direct binding assays and defining what conditions those sites are
used instead of the canonical pqsA promoter.
STD-NMR is a powerful structural technique to monitor the interaction between
small molecules and proteins [181]. This in vitro assay confirmed the interaction of DHQ
with PqsR and also began to determine the molecular interactions involved. We were able
to use a truncated form of PqsR containing the ligand-binding domain to determine the
Kd, residence time of the molecule, and moieties on DHQ responsible for binding. The
technique relies on measuring the signal from the ligand before and during different
titrations to a protein. Titrating DHQ to PqsR showed DHQ was in fast-exchange and that
a certain hybridized C-H on DHQ is the donor group to form a hydrogen bond with PqsR.
Both in vitro methods, STD-NMR and EMSA, determined the Kd for PqsR with DHQ to
be in nanomolar concentrations. Further analysis of the interaction should focus on
showing the structure of PqsR bound to DHQ. PqsR can be double-labeled, which allows
for higher-order analysis of the structure via 2D and 3D techniques. Double-labeled
protein can be used with two specific experiments in order to better determine the effects
of titration on binding and the binding site. Structures of bound and unbound forms of
PqsR would also show any potential structural changes that take place during binding and
how that may preference activation for DNA binding.
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In a single cycle of QS, QS systems are activated and produce molecules that
leave the cell. At a certain intracellular concentration following diffusion, transcriptional
regulators initiate and this process repeats in a positive manner. There is limited
information as to what may continue to happen within a mature community after initial
activation of QS systems. Often long term growth requires a balance with the
environment and cellular stress response systems that can maintain DNA and cell
integrity despite self-inflicted stress. It is not understood how QS systems are involved
during long-term growth. We hypothesize the Pqs and Rhl systems continue to be active
over time and initiate a circadian rhythm by which only one QS system is active and the
other is repressed. The rationale is that products from these systems are both essential for
gathering nutrients and also maintaining the local environment. Therefore, QS activation
of the systems are important because these products may become depleted and need
replenishing. An interesting question for future research may focus on how
environmental signals alter QS in order to gather those nutrients to maintain the essential
or pathogenic systems.
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DHQ and QS molecule consortia in CF sputum samples

QS is involved in virulence factor production and biofilm formation in response to
bacterial density in the environment. Most of the data gathered to support these
interactions were performed in vitro, but only limited experiments have attempted to
determine the properties of QS in vivo. Work on bacterial density has shown that bacteria
do not need to grow to large numbers in order to communicate, rather a few cells in a
small area can synchronize phenotypes [218]. Therefore, only a few bacterial cells are
needed to enact QS regulation given the right environment together and capacity to
exchange QS molecules. These small communities are significant because CF sputum
contains small macrocolonies of bacteria that resemble small biofilm structures.
We understand QS in a test-tube, but the environment has a dramatic effect on QS
regulation. Limited nutrients, oxygen, and loss of QS molecules to the environment are
some examples of different environments that alter QS. The environment that P.
aeruginosa colonizes in an infection has taken recent interest in the research community
and will be an area that will help compare QS phenotypes between in vitro and in vivo
conditions.
During chronic colonization of the CF lungs, P. aeruginosa undergoes several
genotypic and phenotypic changes. These changes are both self-inflicted and induced by
the environment. Following mutation, P. aeruginosa is under constant pressure for
adaptation. The selective pressures in the lungs create a diverse community of P.
aeruginosa cells that display different phenotypes and begin to resemble multicellular
communities [219]. QS systems are frequently mutated throughout chronic colonization,
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for example, the Las system is often mutated and losses function after colonization [220].
The Pqs system is another system that can also be mutated, but this is found much less
often and requires the other QS systems to maintain function. When considering the
interactions of QS and long-term growth, chronic colonization adds more complexity to
understand how QS molecules can be interpreted as the active phenotype..
One limitation to studying QS molecules as a connection to disease severity and
bacterial phenotypes is the poorly understood natural progression of molecules within the
host environment. Bacteria synthesize QS molecules that accumulate in the environment,
but the duration and integrity of the QS molecules is less understood. In the environment,
molecules are subject to chemical conditions, which may cause them to breakdown. QS
molecules may also be lost to physical processes and degradation by secreted enzymes.
These changes to QS molecules will alter the concentration quantified from patient
samples and may not represent the phenotypes found in vitro. The alterations in QS
molecules will subsequently distort the conclusions reached based on QS molecules as
biomarkers. Engineered in vitro systems may help to recapitulate those systems found
within the lungs that alter the concentration of QS molecules and would help to assess
phenotypes of bacteria.
In order to assess QS molecule dynamics within the sputum, imaging mass
spectrometry may be used with sections of mucus to investigate the accumulation of
molecules [221]. Another future focus for QS biomarker research is mucus production,
which is affected by several different treatments, i.e. DNases, hypertonic saline, and
respiratory therapy. Our patient study assessed sputum from different CF patients
throughout their treatment. We could not control the quality of sputum, time of
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production, or the therapies the patients received, but we did ensure enough sputum was
given in order to extract QS molecules. Working with the CF respiratory therapists, we
were able to gather sputum both independently in the clinic and also following percussion
therapy. Hospitalized patients gave samples during a morning routine with the respiratory
therapists as well. Together, sputum sampling offered a convenient mechanism for
sampling CF patient lungs, but will require further optimization for quality and
reproducibility.
In order to reduce attack from the immune system, P. aeruginosa produces
molecules that reduce signaling and viability of immune cells. For an opportunistic
bacterium that resides in diverse natural environments, it is interesting to find a bacterial
system that regulates host functions so efficiently. An important unanswered question to
understand is what are the selective pressures that maintain production of DHQ. .We
have found evidence that DHQ may be actively involved in dampening the host immune
response. During an infection, reducing macrophage activity limits the inflammatory
response that P. aeruginosa faces in the lungs. Other QS also affect the inflammatory
response, which may have an effect on how P. aeruginosa protects its microenvironment
during an infection. Future studies of the role of QS and inflammation should investigate
the QS molecules together as a consortium in order to determine the complicated
interactions that are involved.
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Future Directions

DHQ plays both specialized and redundant roles for the Pqs system, but most
importantly, DHQ is produced in high concentrations. Bacteria do not waste resources
and quickly adapt their phenotypes. Those systems that are not essential for P.
aeruginosa are selected against overtime. Our research focused on the importance of
DHQ to P. aeruginosa during an infection. We found that production of DHQ maintained
pathogenicity towards an infection model when synthesis of the other quinolones was
stopped. However, DHQ did not perform as a signaling molecule to the same level
compared to HHQ and PQS. What we did conclude was DHQ played a significant role as
an extracellular molecule against host cells, regardless of oxygen present. An important
unanswered question is what role DHQ plays for P. aeruginosa during its colonization of
a soil or aquatic environment. These environments are the reservoir of P. aeruginosa. As
an opportunistic infection, P. aeruginosa only causes disease when a barrier is broken
down. Therefore, P. aeruginosa persists in the environment until it comes into contact
with a host. For P. aeruginosa to maintain DHQ production host-to-host, DHQ must play
a role that is not selected against. For most bacterial pathogens, this question is often
unanswered for secondary metabolites.
From the Pqs system, a large group of quinolones is produced. However, apart
from the alkylquinolones, DHQ is the only terminate non-alkylated product. With this in
consideration, a future question may involve the evolution of DHQ synthesis away from
the other quinolones. Two hypotheses provide possibilities as to why DHQ diverged
within the Pqs system. First, DHQ formation preceded synthesis of alkylquinolones,
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which were developed for better signaling and transcriptional regulation. Also, the
lowered ability for signaling may indicate that the extracellular role for DHQ was
originally utilized by P. aeruginosa followed by some QS activity with the molecule. An
alternative hypothesis is that DHQ was more recently developed from the Pqs system. As
the Pqs system became more pivotal for survival, alkylquinolones were produced as an
expensive signaling molecule. In order to produce quinolones optimally, DHQ was
synthesized because its precursors are significantly more abundant in an environment.
Development of DHQ production after establishment of alkylquinolone signaling would
only come from a selective pressure that DHQ fulfills. The selective pressure for this
adaptation would likely remain with P. aeruginosa. Research needs to determine what
environmental factors potentiate the use of DHQ for increased P. aeruginosa survival.
The use of DHQ as an anti-inflammatory drug requires further investigation, but
offers an exciting outlook for the molecule. The extracellular effects of DHQ were
dramatic against host cells because the results indicated DHQ reduced cellular viability
and key inflammatory signals. DHQ treated lung epithelial cells displayed reduced
cellular replication, but no outward effect on cellular morphology or metabolism.
Reduced MTS reading from the epithelial cells were a result of lower cell number. The
effects of DHQ against alveolar macrophages were different in that DHQ was toxic
towards the host cells based on reduced MTS reading and similar cell counts compared to
vehicle treatment. LPS-activated macrophages also produced fewer cytokines as a result
of DHQ treatment. Previous work demonstrated quinolones reduced NF-kB signaling,
which is responsible for activating cytokine production. Future work may also determine
if DHQ also has an effect on IL-10 production, which is an anti-inflammatory cytokine.
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Because of the low toxicity and low micromolar concentration required to reduce
cytokines, DHQ is a good scaffold for further development of anti-inflammatory
compounds.
Recently published work identified overactive inflammation as an agent of several
diseases [222]. The reason for over-active inflammation was a result of the inability to
reduce the signaling cascade after initiation. DHQ may be used in these situations to
lower patient inflammation, but not critically limit the immune system to the point of
predisposing those to opportunistic infections.
QS systems can be targets for inhibition that would reduce pathogenicity of
bacteria. Because QS systems are essential for initiating an infection in models, inhibiting
QS would allow the host’s immune system to kill the bacteria. Several groups have
identified compounds that block QS in vitro and also have some success in vivo.
However, no drug has been brought to market as a result of the research. Researchers
have encountered issues with access to targets, solubility of compounds, and
identification of targets that have maximum effect. PqsR may be the most effective
because of its regulation of the pqs and rhl operons [223]. Loss of PqsR would result in
blocked quinolone production, reduced ability to form communities, and lowered
pyocyanin production. These are all key factors that make P. aeruginosa a successful
pathogen. In fact all transcriptional regulators are potential targets for inhibition because
of their investment in QS, biofilm formation, and virulence factor production [51]. Future
work can exploit the structural determination of the transcriptional regulators and new
methods of drug delivery.
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Methods
1. Bacterial strains, plasmids, and media
P. aeruginosa wild-type strain PAO1, derived mutants, and E. coli strains were
grown in Luria–Bertani (LB) medium at 37°C in a shaker incubator. Cystic fibrosis
mimic media was created according to Palmer et al [23]. Hypoxic conditions were
created by flushing media with N2 for 10 min and incubating cultures within a screw-cap
vial sealed with a Tephlon© insert. All strains and plasmids used are listed on Table 1.
When necessary, 200 or 50 µg/ml carbenicillin (CBC), 30 µg/ml kanamycin (Km), and/or
34 µg/ml chloramphenicol was added to the culture medium. Culture density was
assessed by measuring absorbance at 600 nm. DHQ (2,4-dihydroxyquinoline) was
purchased from Sigma-Aldrich and PQS (2-heptyl-3-hydroxy-4-quinolone) and HHQ (2heptly-4-quinolone) were purchased from Qingdao Vochem Co..

2. Generation of mutants
P. aeruginosa mutant strains were generated by homologous recombination using
a protocol described previously [224]. The mutant alleles were constructed by
overlapping PCR to contain a gentamicin-resistance cassette flanked by 5’ and 3’
fragments of the gene to be deleted. The mutant fragments were inserted into
pEX18ApGW, a suicide vector, to produce gene knockout plasmids. Each knockout
plasmid was transformed into E. coli strain SM10 and conjugally transferred from SM10
to PAO1. The resultant integrants were selected on PIA medium containing 30 µg/ml
gentamicin. To ascertain resolution of merodiploids, Gmr colonies were streaked for
single colonies on LB+Gm30 plates containing 5% sucrose. The unmarked deletion
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mutants were generated by Flp-mediated marker excision utilizing pFLP2. Potential
mutants were screened by PCR using corresponding flanking primers, and were
confirmed by sequencing.

3. Generation of protein-expressing plasmids and protein purification
Gene fragments of PqsR and PqsR-C87 were PCR amplified and digested with restriction
enzymes. Digested fragments were cloned into ppSUMO before transformation into
Promega JM109. Colonies isolated following transformation were sequenced to ensure
integrity and directionality of the insert. BL21(DE3) and Rosetta were transformed with
the expression plasmids for protein production. Briefly, E. coli containing the expression
plasmids were grown in LB to OD600 of 0.6 and heat-shocked at 45°C for 45 min,
followed by induction with 0.1mM isopropyl β-D-thiogalactopyranoside at 16°C for 16 h.
The cells were harvested by centrifugation and resuspened in Tris-HCL (pH 8.0), 500
mM NaCl and lysed using sonication (40% amplitude, 15 sec sonication with 45 sec
break for 5 min). His-tagged protein in the cell-free supernatant was purified using nickel
affinity chromatography. The fractions containing pure protein were pooled,
concentrated, and stored either at -80°C or with 50% v/v glycerol at -20°C. Protein
concentration was determined using the Bradford method [225].

4. Caenorhabditis elegans survival and imaging.
Bristol N2 strain of C. elegans was maintained and synchronized on nematode
growth media (NGM) containing E. coli OP50 according to the worm book [226].
Synchronized L4 nematodes (around 30 per plate) were transferred to 60 mm petri dishes
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with bacterial lawns of the P. aeruginosa strains, which had been incubated overnight at
37°C. Assays were conducted at 25°C and nematodes were monitored daily for survival.
Dead nematodes were determined after no movement following stimulation with a
platinum wire. To assess in vivo bacterial colonization, P. aeruginosa strains carrying a
GFP-expressing plasmid were used for infection. At the indicated time-points, nematodes
were removed and allowed to move on fresh agar to remove bacteria attached to the
outside of the nematodes. These nematodes were placed into a 10 µl drop of water on a
glass slide and covered with a cover slip. Samples were viewed using a Nikon TE2000-S
Epifluorescent microscope with CRI-Nuance imaging system. Images were colorenhanced and analyzed with ImageJ (NIH).

5. Pyocyanin quantification
Pyocyanin was measured using a modified protocol from previous work [227].
Briefly, 400 µl of overnight culture cell-free supernatant was mixed with 240 µl
chloroform. After mixing vigorously, 200 µl of the organic phase was transferred to a
new tube and mixed with 60 µl 0.2 N HCl. Pyocyanin was measured
spectrophotometrically at 520 nm using a NanoDrop ND-1000 spectrophotometer.

6. Quantitative Real Time PCR (qRT-PCR)
P. aeruginosa strains were grown in LB until early stationary phase. Total RNA
was harvested using 5-Prime PerfectPure Cultured Cell kit according to the
manufacturer’s instructions. RNA was treated with DNaseI and precipitated overnight at 20°C using the Ambion DNase treatment and removal kit. cDNA was generated using the
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Bioline Tetro cDNA synthesis kit and manufacturer’s instructions. Bioline SensiFAST
SYBR&Fluorescien kit with cDNA and primers for pqsA and rpoD were run on a BioRad MyIQ RT-PCR detection system. The expression levels of pqsA were measured as
previously described [228].

7. pqsA’-LacZ fusion reporter assay
LacZ reporter assay was performed in both E. coli and in P. aeruginosa strains as
previously described [176]. Briefly, overnight cultures of E. coli:pEAL08-2 was diluted
to OD 600 nm 0.05 and grown in the presence of quinolones for 2 h, followed by
centrifugation of the cells. P. aeruginosa strains with pEAL08-2 were grown overnight
after dilution to OD 600 nm 0.05. Cells were lysed and activity was measured using the
Promega β-galactosidase enzyme assay kit and measured at absorbance 420 nm on a
BioTek Synergy HT plate reader.

8. Electrophoretic Mobility Shift Assay (EMSA)
Protein-DNA gel retention assays were performed using cell lysates from PAO1,
pqs mutants, and Rosetta strains induced for SUMO or SUMO-PqsR production as
described [176]. For each sample, 10 µg of cell-lysate was incubated with 0.15 fmol of
biotinylated-pqsA that was generated from PCR amplification with biotinylated-primers
with the Pierce LightShift Chemiluminescent EMSA kit (10mM Tris-HCL, pH8.0, 1mM
EDTA, 50mM NaCl + 1mM Dithiothreitol + 1 µg/µl Poly(dIdC)) and 0.5x Tris Borate
EDTA (TBE) buffer for 20 min at room temperature (24°C). Unlabeled pqsA was
generated using the same primers as the Bio-pqsA, but without the biotinylation tag.
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Samples were run at 100 V for 50 min on a 5% polyacrylamide gel and transferred onto a
positively-charged nylon membrane at 40 V for 1 h. The nylon membrane was processed
with the chemiluminescence kit and exposed to either X-ray film or GE ImageQuant RTECL.

9. Saturation Transfer Difference NMR
STD NMR experiments were prepared with 1 µM SUMO-PqsR-C87 with increasing
concentrations of DHQ (10 nm to 100 µM). Data was collected at 298K on a Bruker
Avance III 600 MHz NMR spectrometer equipped with a 5 mm cryogenically-cooled
QC-Inverse and using a standard STD pulse sequence with 30 ms 8.4 kHz spin lock to
minimize background protein resonances [229]. Solvent suppression was achieved using
the excitation sculpting scheme. Saturation of the protein signals was performed using a
train of 10, 20, or 59 selective 56 dB Gaussian pulses of 50 ms duration with total
saturation times of 0.25 sec to 5.0 sec. The on-resonance frequency was set up at -0.5
ppm. STD spectra were acquired from 64 scans, 2050 receiver gain, and 14 ppm sweep
width.

10. Quantification of quorum-sensing molecules
PAO1 aerobic and anaerobic cultures were grown overnight. Cultures were spun
down and the supernatant was collected and acidified with 0.1% formic acid. HPLC
purification was carried out using a WATERS HPLC system (HPLC 2767 Sample
Manager), 1525 WATERS 2996 PDA and WATERS ZQ Single Quadrapole Mass
Detector outfitted with MASS LYNX software (Waters Corporation, Milford, MA). The
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HPLC/MS method was water/acetonitrile (ACN) gradient with 0.1% formic acid in both
solvents. Samples were loaded onto an Ascentis Express C18 (Sulpeco Analytical) 5 µm
particle size, 150 mm x 21 mm column. The flow scheme conditions were: 0.4 ml/min
flow rate, 70:30 water/ACN (hold for 2 min). This was followed by a linear gradient over
30 min to 100% ACN. The 100% ACN was held for 5 min prior to re-establishment of
original flow conditions. Column temperature was held at 30°C.

11. Cell viability and total cell counts
Human A549 lung carcinoma cell line and murine RAW264.7 alveolar
macrophages were maintained in RPMI supplemented with 10% fetal bovine serum at
37°C with 5% CO2. Cells were maintained in flasks and transferred at confluency to 96well plates (2x104 per well). After transferring, cells were treated with quinolones in
DMSO. Viability of cells was assessed by MTS assay using the Promega CellTiter 96
aqueous non-radioactive cell proliferation kit according to manufacturer’s instructions.
Total cell counts were performed in 24-well plates (2x104 per well for A549 cells and
3x103 per well for RAW264.7 cells) with a single quinolone concentration for treatment.
A549 cells were removed for numeration using 0.05% trypsin and RAW264.7 cells were
removed using a cell scraper. Cells were treated with Trypan blue and counted using a
haemocytometer.

12. Molecular modeling
Docking studies were performed using GOLD software package 5.1. (Cambridge
Crystallographic Data Centre, Cambridge, UK). The X-ray coordinates of PqsR (4JVD,
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4JVC, and 4JVI) were downloaded from the Protein Data Bank. The active site was
determined from both 4JVD and 4JVI. Docking of DHQ with PqsR was energy
minimized and scored using ChemPLP. Of the possible sites generated by modeling, the
highest fitness score provided the potential interactions to diagram. Molecular Operations
Environment (MOE) was used to diagram DHQ within the PqsR hydrophobic binding
pocket.
13. Extraction of QS molecules from sputum
Sputum was measured for volume and extracted with 2 volumes of ethyl
acetate. The organic phase of the extraction was dried down under nitrogen and
rehydrated in formic acid and ethanol. Samples were maintained at -20⁰C until
processed through LC-MS.
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